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Alkyladenine DNA glycosylase (AAG) initiates the base excision repair pathway 
that repairs damage to single bases within DNA. AAG recognizes lesions caused by 
alkylation and deamination. AAG first locates the site of damage then excises the 
damaged base, leaving an abasic site in the DNA that is further processed by other repair 
proteins to complete the pathway. Although many substrates have been identified and 
there are high resolution structures, our understanding of the AAG mechanism remains 
incomplete. To investigate this further, the thermodynamics and kinetics of binding and 
base-flipping, along with structural conformational changes of AAG, were investigated. 
The thermodynamics of AAG binding to damaged and undamaged DNA was examined 
using fluorescence anisotropy. Surprisingly, this revealed that multiple proteins could 
bind with nanomolar affinity to short DNA oligonucleotides, which might be a common 
phenomenon for DNA repair enzymes. These results reveal the pitfalls of studying DNA 
binding by fluorescence anisotropy, since nonspecific binding dominates the changes in 
signal. The kinetic mechanism of the AAG reaction with 1,N
6
-ethenoadenine (εA)-
containing DNA was established, including binding, nucleotide flipping, base excision, 
and product release steps, by taking advantage of the natural fluorescence of the εA 
lesion. We observed that the flipping step is fast and the equilibrium for flipping is highly 
favorable. This kinetic mechanism maximizes specificity between damaged and 
undamaged bases. To study possible conformational changes in AAG, we took two 
approaches. First, tyrosine residues in the active site pocket were mutated to tryptophans 
xiv 
 
to serve as fluorescence reporters. We found Y127W and Y159W mutants had robust 
activity towards εA. However, a full kinetic characterization revealed that these 
mutations have large effects on the rates and equilibria for flipping. This suggests these 
mutants will have limited utility in studying recognition and flipping of other damaged 
nucleotides. Secondly, preliminary experiments established the feasibility of using NMR 
to study AAG and provided evidence for extensive conformational changes that take 
place upon binding to DNA. These studies have provided a mechanistic framework that 
will facilitate future investigations into the role of conserved residues and the energetic 
basis for the discrimination between damaged and undamaged DNA. 
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Chapter 1  
Introduction 
 
DNA is subject to many different types of damage from both endogenous and 
exogenous sources such as ionizing radiation, UV radiation, spontaneous deamination, 
alkylation, oxidation and DNA polymerase errors. These sources of DNA damage can 
cause many types of DNA damage, including single or double strand breaks, single base 
lesions, crosslinks and mismatches (1). Failure to repair DNA damage can lead to cancer 
causing mutations or cell death. Since there are only two copies of DNA within each cell 
and these cannot be replaced, it is essential that cells repair the damage. With so many 
types of damage occurring in the DNA, cells have several different pathways of repair, 
including homologous recombination, nonhomologous end joining, base excision repair 
and mismatch repair (2). 
The major pathway utilized to repair damage to single bases within the DNA is 
called the base excision repair (BER) pathway (3-4), which is outlined in Figure 1.1. This 
is the pathway for a monofunctional glycosylase. Other pathways of BER are possible for 
bifunctional glycosylases that also catalyze β-elimination. The first step in the pathway is 
for a DNA glycosylase to recognize a site of DNA damage. The glycosylase cleaves at 
the glycosidic bond, yielding a free base and an abasic site in the DNA. The glycosylase 
likely initiates this reaction by positioning a water molecule in the active site that attacks 
at the glycosidic bond, which can be seen in Figure 1.2 (5). The abasic site is further 
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processed by an AP endonuclease, which nicks the DNA strand 5’ of the deoxyribose. 
The deoxyribose is then removed by a dRP lyase activity. In humans, the major dRP 
lyase activity is provided by the lyase domain of DNA polymerase β. The DNA 
polymerase then fills in the gap in the DNA, using the intact strand as a template. Finally, 
a DNA ligase seals the nick in the DNA strand to complete the repair pathway and restore 
the DNA to its undamaged state. 
 
 
Figure 1.1. Base excision repair pathway initiated by a monofunctional DNA glycosylase. 
Shown is a single base lesion, X, in red and the intermediates formed during the base 
excision repair pathway. Once DNA damage is recognized by a DNA glycosylase, it 
cleaves the glycosidic bond, leaving an abasic site in the DNA. AP Endonuclease binds to 
the abasic site, cleaving 5’ of the deoxyribose, leaving a nick in the DNA strand. The 
dRP lyase activity of DNA polymerase β removes the deoxyribose then the DNA 
polymerase fills in the gap, using the intact strand as a template. DNA ligase seals the 




Figure 1.2.  DNA glycosylase excision reaction. The glycosylase finds a damaged base 
within the DNA, here εA is the lesion shown, and the excision reaction is initiated with 
the attack of the N-glycosidic bond by a catalytic water molecule. The damaged base is 
released into solution and an abasic site is left in the DNA strand, which is further 
processed by the BER pathway to complete the repair. 
It is important for the rest of the pathway to be completed once it has been 
initiated by a DNA glycosylase. This is due to the fact that some of the DNA 
intermediates, such as an abasic site or single strand break, of BER can be more harmful 
to the cell than the original lesion.  
There are ten different known DNA glycosylases in humans (3). Some 
glycosylases are very specific and only recognize one lesion and there are a few that are 
broadly specific and can recognize and cleave many different lesions. As mentioned 
before, there are also monofunctional and bifunctional DNA glycosylases. 
 One of these monofunctional, broadly specific DNA glycosylases is alkyladenine 
DNA glycosylase (AAG). AAG recognizes many different lesions caused by alkylation 
and deamination to purines (6-7), some of which are shown in Figure 1.3. Also shown are 
the undamaged A and G bases, which are not good substrates for AAG. The lesions that 
AAG recognizes are very diverse. Some are positively charged, such as 7-methylguanine 
and 3-methyladenine. Others are large and bulky adducts, such as 1, N6- ethenoadenine 




Figure 1.3.  Diversity of AAG substrates. On the left are the undamaged bases, guanine 
and adenine. The rest of the bases are a subset of the lesions that AAG recognizes as 
substrates. 
hypoxanthine. Thus, there is no common feature about the lesions that allows AAG to 
select for them. Therefore, AAG has methods to select against bases that are not 
substrates, such as undamaged bases. For the undamaged purines, adenine and guanine, 
AAG selects against them due to steric clashes in the active site between the 6-amino 
group of adenine and H136 in the active site or the 2-amino group of guanine and the 
N169 residue of AAG (8). Although pyrimidines are smaller than the substrates cleaved 
by AAG and could presumably fit into the AAG active site, they are selected against due 
to the acid-base catalytic mechanism employed by AAG (5).  
 A high resolution crystal structure of AAG bound to a 13 base pair εA-containing 
DNA oligonucleotide has been previously solved and is shown in Figure 1.4 (9). AAG 
interacts with about 10 base pairs of the DNA. Clearly seen in the structure, AAG 
employs a base flipping mechanism, rotating the εA 180° out of the duplex and into the 
active site in order to orient the glycosidic bond in a position for attack by the catalytic 




Figure 1.4.  Crystal Structure of AAG. AAG is in ribbon representation on the right and 
the 13mer DNA is on the left in blue stick representation. Key active site residues of the 
protein are in blue and the εA lesion is in black. AAG employs a base flipping 
mechanism which can be seen as εA is flipped 180° out of the duplex and into the active 
site of AAG. (9) 
Two tyrosine residues and one histidine residue line the active site pocket and 
interact with the lesion. Y162 intercalates into the DNA duplex to occupy the space that 
is left when εA is flipped. Not highlighted in the structure, but located in the active site is 
the residue E125, which orients the catalytic water molecule so it can attack the 
glycosidic bond of the substrate.  
 The crystal structure of AAG bound to a lesion-containing DNA provides a lot of 
information about the conformational changes that occur during base flipping. To achieve 
the flipped structure seen here, AAG must undergo at least three conformational changes: 
the DNA bends by 20°, the εA lesion flips 180° into the active site of AAG and Y162 
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intercalates into the DNA duplex. However, this structure is static and does not give any 
information about the kinetics of the AAG reaction. 
 Much is known about the substrates of AAG and its catalytic mechanism, but 
little is known about the binding of AAG to DNA. Chapter 2 addresses the 
thermodynamic parameters and stoichiometry of AAG binding to different DNA 
oligonucleotides. 
The kinetic mechanism of εA excision by AAG is addressed in Chapter 3. 
Utilizing the fluorescence of εA, the minimum number of steps and the rate constants for 
each step were determined. This information is extended in Chapter 4, in which the 
conformational changes in AAG were investigated by substituting active site tyrosines 
with tryptophan. The fluorescence of the tryptophan residues in AAG was monitored and 
the fluorescence changes were compared to changes seen in εA fluorescence.  
NMR is another powerful way to investigate conformational changes. In Chapter 
5, preliminary experiments are described that demonstrate the feasibility of doing NMR 
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Chapter 2  
Alkyladenine DNA Glycosylase Binds with High Density to 
Single- and Double-Stranded DNA 
 
Alkyladenine DNA glycosylase (AAG) initiates the base excision repair (BER) 
pathway by finding the site of damage and cleaving at the N-glycosidic bond, yielding a 
free damaged base and an abasic site in the DNA. The abasic site is further processed by 
the rest of the BER pathway to complete the repair. Many DNA repair proteins can use 
nonspecific DNA binding to enable a more efficient one dimensional search of the 
genome (e.g. see (1-4)). Recently, AAG has been shown to use a similar mechanism to 
slide along the DNA to find a site of damage (5).  
Although nonspecific binding is important for locating the site of damage, AAG 
binding to the specific site is important for catalysis to occur. There is little information 
about the affinity of AAG for damaged and undamaged DNA, so the thermodynamics of 
AAG binding to DNA was examined.  
A useful way to measure binding to DNA is by fluorescence anisotropy (6-8). 
With a fluorescent label on the end of the DNA, the fluorescence anisotropy is expected 
to increase when a protein binds to the DNA. This is due to an increase in mass, which 
slows the tumbling in solution. When these experiments were performed with AAG, 
some interesting and unexpected results were found. 
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AAG contains an N-terminal domain that is thought to be involved in protein-
protein interactions. The N-terminal domain has been shown to make a modest 
contribution to AAG processivity under physiological conditions (5). For in vitro 
experiments, the full length protein is not very stable and is difficult to work with. A 
mutant that has truncated the N-terminal domain of AAG, leaving only the catalytic C-
terminal domain, has been made (Δ80 AAG). This truncation mutant is much more stable 
in vitro and has been found to have identical catalytic activity to the full length enzyme in 
a variety of assays (9).  
Glutamate 125 is in the active site of AAG and positions the catalytic water 
molecule so that it can attack the N-glycosidic bond. Mutation of this residue to a 
glutamine abolishes AAG activity (9-10). This E125Q AAG mutant is useful for 
experiments where a catalytically inactive protein is needed. 
Materials and Methods 
Purification of Recombinant Proteins 
 The catalytic domain of human AAG that lacks the first 80 amino acids was 
expressed in E. coli both with and without the catalytically inactive mutation E125Q, 
then purified as previously described (9). The full length human AAG protein (FL AAG) 
was expressed in E. coli and purified as previously described (9). The E. coli protein 
AlkA was expressed in E. coli and purified as previously described (11-12). The human 
protein APE1 was expressed in E. coli and purified as previously described (13). 
The concentration of active AAG for the wildtype proteins (FL AAG and WT 
Δ80 AAG) was determined by burst analysis, using an inosine-containing oligonucleotide 
substrate, as previously described (5). The concentration for the other proteins (E125Q 
10 
 
AAG, AlkA and APE1) was determined by measuring the absorbance at 280 nm and 
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Synthesis and Purification of DNA Oligonucleotides 
The oligonucleotides of lengths 13, 25 and 49 nucleotides were obtained from 
commercial sources and contained a central lesion that was placed opposite of a T. The 
sequences are given in Table 2.1. The oligonucleotides were labeled with a 5’-fluorescein 
(6-fam) label with the duplex oligonucleotides being labeled on the non-lesion containing 
strands. Oligonucleotides containing only normal deoxynucleotides and the abasic site  

























ss εA 25mer 5’-CGATAGCATCCTECCTTCTCTCCAT 
ss T 25mer 5’-ATGGAGAGAAGGTAGGATGCTATCG 
 
a
The double-stranded DNA oligonucleotides are named based on the central lesion or undamaged 
base that is opposite a T and the length of the DNA strand. εA is 1, N6-ethenoadenine and D is 
tetrahydrofuran, an abasic site analog. Two single-stranded (ss) DNA oligonucleotides are also 
shown and named for the central base and the length of the DNA strand. 
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analog, tetrahydrofuran (D), were synthesized and deprotected with standard 
phosphoramidite chemistry. The oligonucleotides containing 1, N6-ethenoadenine (εA) 
were synthesized by the W. M. Keck Facility at Yale University (New Haven, CT), or the 
phosphoramidite was obtained from Glen Research and incorporated using an ABI 394 
DNA synthesizer then deprotected using Ultra-Mild chemistry according to the supplier’s 
recommendations. The oligonucleotides were desalted using Sephadex G-25 and purified 
using denaturing polyacrylamide gel electrophoresis as previously described (5, 9). The 
concentrations of the single stranded oligonucleotides were determined from the 
absorbance at 260 nm, using the calculated extinction coefficients for all oligonucleotides 
except those containing εA. For εA containing oligonucleotides, the extinction coefficient 





was subtracted to account for the weaker absorbance of εA as compared to A (14). The 
lesion-containing oligonucleotides were annealed with a 1.1-fold excess of the 
complement by heating to 90°C and cooling slowly to 4°C.  
Fluorescence and Fluorescence Anisotropy Binding Experiments 
 Fluorescence anisotropy measurements were collected with a PTI QuantaMaster 
fluorometer controlled by FeliX software. To measure anisotropy, both the parallel (I = 
IVV) and perpendicular (I = IVH) fluorescence intensity with respect to the vertical 
excitation light must be measured. The fluorometer was set up in a T-format with 
polarizers set up to let parallel light pass through one side and perpendicular light pass 




Samples were prepared in a buffer containing 50 mM NaHEPES, pH 7.5, 100 mM 
NaCl, 1 mM EDTA, 1 mM DTT, 0.1 mg/mL BSA. All measurements were recorded at 
25°C. Experiments with 10 nM DNA were performed by adding concentrated aliquots of 
protein to 2.5 mL solutions of FAM-labeled DNA and recording the parallel and 
perpendicular fluorescence intensity. For experiments with higher concentrations of DNA 
(100-500 nM), a microcuvette was used and concentrated aliquots of protein were added 
to 200 μL solutions of FAM-labeled DNA and the parallel and perpendicular 
fluorescence intensities were recorded. To measure FAM fluorescence intensity, an 
excitation wavelength of 495 nm (band pass was between 6 and 12 nm) and emission 
wavelength of 518 nm (band pass was between 6 and 12 nm) were used.  
The G-factor was measured by exciting with horizontal light and measuring both 
the parallel (IHH) and perpendicular (IHV) light with respect to the excitation light. The G-
factor is then calculated (G=IHV/IHH). The G-factor is a term that accounts for differences 
in the two different light paths in a T-format fluorometer. 
The total fluorescence intensity was calculated with equation 2.1, where IT is the 
total fluorescence intensity, I = IVV is the parallel fluorescence intensity and I = IVH is 
the perpendicular fluorescence intensity. The anisotropy values were calculated using 
equation 2.2, where r is the anisotropy, I = IVV is the parallel fluorescence intensity, I = 
IVH is the perpendicular fluorescence intensity and G is the G-factor (8).  




 (Equation 2.2) 
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For experiments measuring εA fluorescence, an excitation wavelength of 310 nm 
(4 nm band-pass) and emission wavelength of 410 nm (612 nm band-pass) were used. 
When equilibrium binding constants were able to be measured, the data were fit to 
Equation 2.3, where Fbound is the fraction bound, [DNA] is the initial concentration of 
DNA, [E] is the concentration of AAG, Kd is the dissociation constant. The second phase 
of the anisotropy data was fit to Equation 2.4, which was Equation 2.3 that was changed 
so that [E] was replaced with ([E]-C), where C is the nonzero y-intercept, . 
𝐹𝑏𝑜𝑢𝑛𝑑 =
 𝐷𝑁𝐴 + 𝐸 +𝐾𝑑− ( 𝐷𝑁𝐴 + 𝐸 +𝐾𝑑 )
2−4 𝐷𝑁𝐴 [𝐸]
2[𝐷𝑁𝐴]
 (Equation 2.3) 
𝐹𝑏𝑜𝑢𝑛𝑑 =
 𝐷𝑁𝐴 +( 𝐸 −𝐶)+𝐾𝑑− ( 𝐷𝑁𝐴 +( 𝐸 −𝐶)+𝐾𝑑 )
2−4 𝐷𝑁𝐴 ( 𝐸 −𝐶)
2[𝐷𝑁𝐴]
 
  (Equation 2.4) 
Results and Discussion 
Anisotropy Shows High Density Binding of AAG to εA-Containing DNA 
Experiments were done to compare εA·T 25mer DNA binding by both full length 
AAG (FL AAG) and the N-terminal truncation mutant (Δ80 AAG) to see if the N-
terminal domain of AAG plays a role in AAG binding. When full length AAG (FL AAG) 
was used, the anisotropy saturates at a high [AAG] (Figure 2.1A). The anisotropy also 
reaches a much higher value than is expected for a protein the size of AAG binding to a 
25mer oligonucleotide (see below). Additionally, the FAM fluorescence seen during the 
binding experiment quenches at a high [AAG] (Figure 2.1B). These results were 
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unexpected and suggest that FL AAG is binding at high density to this DNA. On the 
timescale of this experiment, no appreciable glycosylase activity was expected. 
We are using “high density binding” to represent the idea that multiple AAG 
molecules are binding to a single DNA oligonucleotide. In fact, more AAG molecules 
can bind than is predicted by the footprint of AAG from the crystal structure (see below). 
These experiments indicate that AAG is binding at high density due to the large change 
in anisotropy seen when AAG is bound to the DNA and the high stoichiometry necessary 





Figure 2.1. Binding of full length and Δ80 AAG to εA-containing DNA. Experiments were 
performed to compare the effect of the N-terminal domain of AAG, which is truncated for Δ80 
AAG, on binding to 10 nM εA·T 25mer. Δ80 WT AAG ( ) and full length WT AAG () were 
each added to the DNA in small increments. (A) The anisotropy shows that the curves for each 
protein reach a high saturating value, which indicates that both Δ80 WT AAG and FL WT AAG 
bind at high density to DNA. (B) The quenching in FAM fluorescence intensity is also shown. 
Data shown is from single experiments. 
When Δ80 AAG was added to the same DNA, a similar result was seen (Figure 
2.1A and B). Although the two experiments do not reach the same final anisotropy value, 
it takes a greater than 1:1 ratio of AAG: DNA to achieve saturation of the anisotropy 
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signal. Even without the N-terminal domain, AAG can still bind at high density to DNA. 
Additionally, the FAM fluorescence quenching curve is very similar to that of FL AAG, 
which suggests that the two proteins have similar behavior. The rest of the experiments 
described here use Δ80 AAG since it is more stable in vitro.  
Since the experiments are performed under equilibrium conditions, it would be 
advantageous to use a catalytically inactive mutant of AAG to perform these experiments 
in order to prevent catalysis from occurring. Binding to εA·T 25mer DNA by wildtype 
Δ80 AAG and E125Q AAG was measured (Figure 2.2). For both proteins, high density 
binding was seen. However, some differences in the two binding curves were apparent. 
The final anisotropy value is higher in the experiment with E125Q AAG than with WT 





Figure 2.2. Comparison of WT to E125Q AAG. Experiments were performed with 10 nM εA·T 
25mer and Δ80 E125Q AAG ( ) or Δ80 WT AAG (). (A) The anisotropy plots both show a 
high saturating value, indicating that E125Q AAG exhibits a similar behavior of binding at high 
density to εA·T 25mer as seen with Δ80 WT AAG. This suggests that using the E125Q mutant is 
a valid substitution to use, which prevents excision by AAG. (B) The change in FAM 
fluorescence intensity is also shown. Data shown is from single experiments. 
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This indicates that E125Q AAG binds more tightly to nonspecific sites than WT AAG 
does. The FAM fluorescence showed similar curves quenching for the two proteins, but 
FAM quenching saturated at a lower concentration of AAG for the E125Q mutant. Since 
the E125Q mutant has no glycosylase activity (9-10), the remainder of the experiments 
used this protein. 
To test that the high density binding is real and not an artifact, experiments were 
performed at different concentrations of εA·T 25mer DNA (Figure 2.3). Figure 2.3A and 
C show the raw data from the experiments, while Figure 2.3B and D show the data after 
it has been normalized for the difference in DNA concentration. This normalization to 
equivalents of AAG enables a direct comparison of the three experiments. Figure 2.3D 
was also normalized in the y-axis, showing the FAM quenching on the same scale. These 
experiments show the same break in the curve at 1:1 stoichiometry (Figure 2.3B). In all 
three experiments, a similar linear curve is seen up to a 1:1 ratio of AAG: DNA. The 
most likely explanation for this is that AAG binds with highest affinity to the lesion site 
on the DNA and this is saturated at a 1:1 ratio of AAG: DNA. As the concentration of 
AAG is further increased beyond 1:1, the anisotropy continues to increase, indicating 
AAG molecules are binding to other, nonspecific, sites on the DNA. 
When the high concentration of DNA (500 nM) was used, there is a pronounced 
separation between the two phases of the curve. For the middle concentration of DNA 
(100 nM) a separation between the two phases is seen, yet it is less pronounced than for 
the high concentration of DNA. Because of this distinct separation between the phases in 
the curves for both of these concentrations of DNA, these curves are similar and suggest 









Figure 2.3. Binding of E125Q AAG to εA-containing DNA at different concentrations of DNA. 
E125Q AAG was added to εA·T 25mer DNA at concentrations of 10 nM (), 100 nM () and 
500 nM ( ). The raw data from these experiments are shown in panels (A) and (C), displaying 
the anisotropy and FAM fluorescence intensity, respectively. Each binding curve is achieving a 
high maximal anisotropy value. The FAM fluorescence intensity shows a decrease in intensity as 
more than one equivalent of AAG binds to the DNA oligonucleotide. The data in panels (B) and 
(D) are both plotted on an x-axis that is [AAG]/ [DNA] to get equivalents of E125Q AAG added, 
showing anisotropy and the FAM fluorescence intensity normalized to the signal from the DNA 
alone, respectively. This conversion allows the three curves to be compared directly and shows a 
similar linear behavior up to a 1:1 ratio of E125Q AAG: DNA. The curves diverge after the 1:1 
concentration, with the 500 nM DNA data showing a more pronounced separation between the 
two phases of the curve. As the [DNA] is decreased, it becomes closer to the Kd and is influenced 




nM), there is not a prominent separation between the two phases of the binding curve, 
suggesting that equilibrium binding is influencing the nonspecific binding curve. This 
indicates that the Kd for nonspecific binding is now greater than [DNA]. This data gives 
that the Kd for AAG binding to nonspecific DNA is between 10 and 100 nM. This result 
that AAG binds more tightly to the εA lesion than the nonspecific sites on the DNA gives 
an upper limit for the Kd of AAG binding to εA on the order of 10 nM, which is 
consistent with previous measurements of ~20 nM (10, 15).  
 The normalized FAM fluorescence from these experiments is seen in Figure 2.3D, 
which shows very similar curves for all three concentrations of DNA. The FAM 
fluorescence shows little change up to a 1:1 stoichiometry then quenching can be seen up 
to a stoichiometry of ~3:1. After this, no further change in FAM fluorescence is seen. It is 
likely that this is caused by the first AAG molecule binding at the site of damage in the 
center of the DNA, which does not change the environment of the FAM molecule. When 
one or more of the additionally bound proteins binds, it is then physically close to the 5’ 
end of the DNA, resulting in increased quenching of the FAM. When the FAM 
quenching no longer changes at high concentrations of AAG, this suggests that the DNA 
is fully saturated with AAG molecules. 
One of the limitations of these experiments is that the theoretical maximum 
anisotropy value is 0.4. It is likely that the maximum anisotropy value we can measure in 
this system is even less than that since there is flexibility in the linker region between the 
DNA and the FAM label. This limitation exists because the fluorescence lifetime of 
fluorescein (4 ns) (16) restricts the maximum anisotropy signal that can be detected. 
Since most of the binding curves saturate around an anisotropy value of 0.3, it is possible 
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that there could be more AAG molecules binding to each DNA. This means that the 
saturation of the anisotropy signal does not necessarily indicate that the DNA is saturated 
with AAG molecules. If a fluorophore with a longer lifetime than FAM was used, the 
experiments could reach a higher anisotropy value, it could reveal a greater ratio of AAG: 
DNA binding. Since the FAM fluorescence does not have these limitations, it is expected 
that quenching of the fluorescent signal is indicative of the DNA being fully saturated 
with AAG molecules.  
Simple 1:1 Binding Seen with APE 1 
 Since these results are unusual, we examined the binding of a different protein, 
Human AP endonuclease 1 (APE1) to a similar DNA. APE1 catalyzes the second step in 
BER, where it cleaves the DNA backbone at an abasic site. Studies have shown that 
APE1 is also active on the stable abasic site analog, tetrahydrofuran (D) (17). A recent 
study used fluorescence anisotropy to characterize binding of APE1 to a D-containing 
DNA (18). A Kd value of 11 nM was obtained from these experiments. The paper also 
showed that APE1 binds at a 1:1 ratio to the D-containing DNA oligonucleotide. APE1 
was chosen for comparison in this assay because it binds at a 1:1 ratio and it is of similar 
size to Δ80 AAG (37 kDa and 24 kDa, respectively) (19). Since it is of similar size to 
AAG, it would be expected to give comparable anisotropy changes when binding to a 25 
base pair DNA molecule. The experiment was done with 100 nM DNA, which is far 
above the Kd for APE1 binding to a 25 base pair oligonucleotide, which means that a 
titration was performed. The titration was done in the absence of magnesium, which is a 
required cofactor for APE1 activity. This prevented any cleavage from occurring during 
the experiment, allowing an equilibrium measurement. Figure 2.4 shows the titration with 
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D·T 25mer and APE1. It shows a simple 1:1 binding curve for this enzyme since the 
titration saturates when the concentration of APE1 equals that of the DNA. The final 
anisotropy value of ~0.1 is what is expected when a protein of this size binds to a 25mer 
duplex. The FAM fluorescence does not change during the experiment, which suggests 
that no protein is binding near the end of the DNA. Using APE1 in this titration verifies 





Figure 2.4. Titration of THF-containing DNA with APE1. Shown are the anisotropy (A) and the 
FAM fluorescence intensity (B) when 100 nM D·T 25mer DNA was titrated with APE1. APE1 
shows a well behaved titration curve that represents 1:1 binding. The FAM fluorescence intensity 
shows no significant change throughout the titration. Data shown is from a single experiment. 
AlkA Shows Complicated Binding 
The 3-methyladenine DNA glycosylase II from E. coli (AlkA) also excises εA 
from DNA. It was used to examine binding by a different glycosylase to εA·T 25mer 
DNA (Figure 2.5). AlkA shows that a high concentration of protein is needed to reach a 
saturating anisotropy value. No change in FAM quenching is also seen up to a 1:1 ratio, 
while modest FAM quenching is seen at greater than 1:1 for this experiment. It will be 
necessary to repeat this experiment with another concentration of DNA to rule out the 
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possibility of this being equilibrium binding with a Kd of ~500 nM. More work needs to 
be done to examine if AlkA can bind at high density to undamaged DNA and also to see 
if this high density binding is a more common phenomenon among glycosylases than 
previously thought.  
 (A) (B)
 
Figure 2.5. Binding of AlkA to εA-containing DNA. WT AlkA was added to 100 nM εA·T 2501 
to measure binding. The measured anisotropy (A) and FAM fluorescence intensity (B) are shown. 
AlkA appears to bind similarly to AAG in that the anisotropy saturates when greater than 1 AlkA 
molecule is bound. Data shown is from a single experiment. 
AAG Binds Specifically to εA Site 
In Figure 2.6, binding of AAG to damaged (εA-containing) and undamaged DNA 
oligonucleotides are compared for 25mer (A and B) and 13mer DNA oligonucleotides (C 
and D). Both experiments show that AAG binds to damaged DNA differently than it does 
to undamaged DNA. For the 25mer anisotropy data (Figure 2.6A), there is a small change 
in anisotropy up to a 1:1 ratio of AAG: DNA with the εA·T DNA followed by a large 
change in anisotropy when more AAG molecules bind. However, with the A·T DNA, the 
binding curve shows only one phase of binding. This clearly shows that there is a 
difference in binding to specific and nonspecific DNA molecules. AAG binds with higher 
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affinity to the specific site than to the nonspecific sites since the specific sites are all 
occupied when AAG binds with 1:1 stoichiometry. Also, seen in the data is that the 
anisotropy of the nonspecifically bound complex is at a higher value than that of the 
specifically bound complex. The FAM fluorescence intensity for the two experiments is 
very similar (Figure 2.6B) but it can be seen that there is little fluorescence change up to 
a 1:1 ratio of AAG: DNA followed by a large change as more AAG molecules bind for 
the experiment with the εA·T DNA, as seen before. In contrast, the experiment with the 
A·T DNA shows some FAM fluorescence quenching up to a 1:1 stoichiometry. 
For the anisotropy data with AAG binding to the 13mer DNA oligonucleotides 
(Figure 2.6C), there is not as pronounced of a difference between the binding curves. 
There is, however, a large difference in the FAM fluorescence seen with these different 
DNA molecules (Figure 2.6D). The FAM fluorescence for the binding of AAG to εA·T 
13mer increases during the course of the experiment while that from AAG binding to 
A·T 13mer quenches slightly. While there is not an obvious explanation for this, it is 
possible that the proteins binding to each DNA are positioned differently with respect to 
the FAM on the DNA end which could cause the FAM to be in a different environment 
depending on the DNA sequence.  
Specific Binding Seen with εA Fluorescence 
The εA lesion is naturally fluorescent and is highly sensitive to its environment 
(20). This makes it possible to watch the εA fluorescence quench when AAG binds to the 
specific site in εA·T DNA. In Figure 2.7, an experiment was performed in which the εA 







Figure 2.6. Comparison of E125Q AAG binding to damaged and undamaged DNA. Experiments 
were performed with E125Q AAG binding to 100 nM of either εA·T ( ) or A·T () DNA. The 
anisotropy values (A) and FAM fluorescence values (B) are shown for the 25mer 
oligonucleotides. The vertical line denotes the concentration of E125Q AAG where a 1:1 
stoichiometry is reached. Both binding curves show similar ending anisotropy and FAM 
fluorescence intensity values, suggesting that a similar number of AAG molecules are binding to 
each oligonucleotide. A pronounced difference between the two is that the curve from εA·T 
25mer shows very little increase in anisotropy up to a 1:1 ratio followed by a large increase in 
anisotropy when more AAG molecules bind, while the curve from A·T 25mer appears to be a 
single binding curve that represents multiple AAG molecules binding. This difference can be 
attributed to AAG having higher affinity for the εA·T site than for nonspecific DNA so that only 
the specific site is filled until > 1 equivalent of AAG is added. The same data are shown for the 
13mer oligonucleotides as well, with anisotropy (C) and normalized FAM fluorescence (D) 
values. The vertical line denotes the concentration of E125Q AAG where a 1:1 stoichiometry is 
reached. Little difference is seen from the anisotropy data, while the FAM fluorescence shows 
much different behavior with an increase in fluorescence with the εA·T DNA and quenching with 
the A·T DNA. Data shown is from single experiments. 
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fluorescence curves were fit to Equation 2.3, while the anisotropy, showing two phases, 
was fit to a line for the first phase then the second phase was fit to Equation 2.4. The data 
were normalized for easier comparison. There is an obvious difference between the εA  
 
Figure 2.7. Comparison of εA and FAM fluorescence. The binding of E125Q AAG to 500 nM 
εA·T 25mer was followed by measuring both fluorophores on the DNA as well as the anisotropy. 
The fluorescence from the εA lesion ( , solid line) shows a binding curve that saturates at 1:1 
[E125Q AAG]: [DNA] (shown by vertical solid line), indicating that εA fluorescence quenching 
is only affected by an AAG molecule binding to the specific εA site. Anisotropy (, dotted line) 
and fluorescence from FAM were also measured (, dashed line). The anisotropy and FAM 
fluorescence saturate at ~ 3:1 ratio of protein to DNA, indicating that this signal does not saturate 
until multiple proteins are bound. Data shown is from single experiments. 
fluorescence and the other two measurements. The εA fluorescence clearly shows a 
binding curve that saturates at a 1:1 ratio of AAG: DNA. Since εA fluorescence saturates 
at 1:1, it is only reporting on binding of AAG that occurs at the site of damage and is not 
affected by any additional AAG molecules binding nonspecifically. The anisotropy and 
FAM fluorescence, as seen above, saturate at a much higher density of AAG, at ~3:1 
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ratio. While the anisotropy also reports on 1:1 binding of AAG, it also shows large 
changes when more AAG molecules bind to the DNA. The FAM fluorescence is only 
changing when the nonspecifically bound AAG molecules bind and these proteins give a 
large change in that signal. 
More AAG Molecules Can Bind to Longer DNA Oligonucleotides 
Binding experiments were performed with εA·T DNA molecules of increasing 
length in Figure 2.8. A linear deviation to the binding curve is seen with the 13mer, 
25mer and 49mer up to a 1:1 ratio of AAG: DNA, though the curves appear to be 
different from each other. Higher initial anisotropy values are seen for the longer length 
DNA oligonucleotides due to the fact that larger macromolecules tumble more slowly in 
solution, which leads to higher anisotropy values.  
Saturation of anisotropy at similar ending values is then seen at higher 
concentration of AAG for longer DNA oligonucleotides, which indicates that multiple 
AAG molecules are binding to each DNA. As discussed above, saturation of the 
anisotropy signal is not necessarily indicative of saturation of the DNA by AAG 
molecules. This means that it is possible that more AAG molecules can bind to the longer 
DNA oligonucleotides that cannot be detected by anisotropy. In order to assess the 
number of AAG molecules binding to the DNA oligonucleotides, the FAM fluorescence 
data can be analyzed since it is not limited in the way that the anisotropy data is. The 
results of this analysis can be seen in Table 2.2, which includes data for these and several 
other DNA oligonucleotides. It can be seen that more AAG molecules can bind to the 
longer DNA oligonucleotides. This is consistent with the idea that longer DNA molecules 
will have more nonspecific binding sites that the protein can bind to. Even though the 
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number of AAG molecules bound to each DNA is different, a similar binding density is 
seen for all DNA oligonucleotides so that one AAG is bound every 6-10 bases.
(A)  (B) 
 
Figure 2.8. Comparison of binding by E125Q AAG to εA-containing DNA oligonucleotides of 
different length. The binding of E125Q AAG to 100 nM of 13mer ( ), 25mer () and 49mer () 
εA·T DNA was measured. (A) The initial anisotropy values are not the same since this value will 
increase with DNA length. All of the binding curves reach a similar final anisotropy value. Each 
shows a similar linear increase to a 1:1 ratio of [AAG]: [DNA], indicating the formation of a 
specific complex, followed by a binding curve for the nonspecifically bound proteins. Saturation 
is reached at increasing [AAG] as the length of DNA increases. (B) The change in FAM 
fluorescence is shown for comparison of the DNA fluorescence. Data shown is from single 
experiments. 
Interestingly, the FAM fluorescence intensity for the three different length DNA 
oligonucleotides changes in different directions and with different magnitudes when it is 
fully saturated by bound AAG. The 25mer shows a small degree of FAM quenching 
when fully saturated, while the 13mer shows a small increase in FAM fluorescence. The 
FAM fluorescence from the 49mer shows a large increase in fluorescence when it is fully 
bound by AAG. It is not clear why the FAM fluorophores on the DNA molecules of 
different lengths show such different behavior. If is possible that the proteins bound near 
the end of the DNA have different interactions with the FAM molecule. Or there could 
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simply be length dependent or sequence specific differences in the way AAG binds near 
the end of the DNA. 
Table 2.2 shows the number of AAG molecules bound for the different DNA 
oligonucleotides that were studied above. This gives 1-2 AAG molecules bound to the 
13mer DNA oligonucleotides, 3-3.8 AAG molecules bound to the 25mer DNA  
Table 2.2. Comparison of AAG molecules bound to DNA of different lengths. 
DNA 
Number of AAG 
Molecules Bound
a 
Ratio of AAG : DNA 
Base Pairs
b 
A•T 49mer 4.7 1:10 
   
A•T 25mer 3.8 1:6 
A•T 25mer 3.5 1:7 
D•T 25mer 3.0 1:8 
   
A•T 13mer 0.9 1:13 
A•T 13mer 2.2 1:6 
D•T 13mer 1.9 1:6 
a
 The number of AAG molecules bound to one DNA oligonucleotide was obtained by 
determining the concentration of protein where the FAM fluorescence intensity saturated, which 
was then divided by the concentration of DNA in the experiment. 
b
 The ratio of AAG: DNA base 
pairs was determined by dividing the number of base pairs in the DNA by the number of AAG 
molecules bound. 
oligonucleotides and 4.7 AAG molecules bound to the 49mer DNA oligonucleotide. The 
DNA lengths are doubled at each interval and the number of AAG molecules bound also 
doubles between the 13mer and 25mer DNA. The number of AAG molecules is less than 
doubled between the 25mer and 49mer DNA. This could be due to some interaction of 
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AAG with the ends of the 25mer DNA oligonucleotide that requires the AAG molecules 
to pack more tightly along the DNA, while the 49mer, with greater binding sites, does not 
require such tight packing of AAG molecules while still achieving high density binding.  
Also seen in Table 2.2 is the ratio of AAG: DNA base pairs, which is between 6-8 
base pairs for the 25mer DNA oligonucleotides. This appears to be an appropriate 
estimate for the footprint of AAG binding. 
AAG Footprint Comparison 
This remarkably high binding density appears to be in conflict with the known 
structural information. Shown above is evidence that the footprint for AAG binding to 
DNA is 6-8 base pairs. However, the footprint for AAG binding to DNA is predicted to 
be 10 base pairs from the crystal structure (21) and 11-12 base pairs from footprinting 
assays (22). The only way to reconcile these numbers is for the AAG binding sites to be 
overlapping. This is a feasible model because the crystal structure shows that AAG binds 
to only one face of the DNA. Thus, two AAG binding sites can overlap if the proteins 
bind to opposite faces of the DNA. Since the binding sites overlap, this gives AAG 
binding at a higher density to DNA than was predicted by other footprinting assays. The 
high density binding by AAG suggests that AAG can sample very small segments of 
accessible DNA. The data from the 13mer DNA oligonucleotides is the best evidence that 
AAG is able to overlap binding sites in this way since two AAG molecules bind to a 
13mer DNA, giving a footprint of ~6 bases per AAG, which is obviously smaller than the 
footprint for AAG from the traditional assays. 
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 Additional evidence that AAG binds at high density to DNA is a series of 
electrophoretic mobility shift assays (EMSA) that have been done with AAG and 
multiple 25mer DNA oligonucleotides (10, 23-24). These assays show a shift in the 
mobility on a gel between unbound and bound AAG. In many of these assays, an 
additional band or two can be seen above the bound AAG band, which is consistent with 
complexes containing multiple molecules of AAG.  
AAG Binds at High Density to Single-Stranded DNA 
 AAG is also capable of binding to single-stranded DNA (ssDNA). Binding 
experiments were performed with AAG and εA-containing and undamaged ssDNA 
molecules in Figure 2.9, which shows that AAG binds at high density to both. Although 
saturation was not yet reached in the experiment, it required a very high concentration of 
AAG (8-10:1 AAG: DNA) to see the anisotropy changes. This means that AAG can bind 
at a much higher density to ssDNA than to duplex DNA (Table 2.3). This very high 
density of AAG binding to ssDNA is very similar to the binding density of another DNA 
repair protein. Recently the crystal structure of RecA, an enzyme involved in homologous 
repair was solved and it shows that one RecA monomer binds to every three bases of a 
single-stranded DNA (25). 
 Table 2.3 shows a comparison between the footprint for single- and double-
stranded DNA. Clearly, AAG binds with much smaller footprint to single-stranded DNA 
only binding to 3 bases for each molecule, compared with 6-8 bases per molecule for 
double-stranded DNA. Perhaps AAG is able to extend the single-stranded DNA so that it 
can fit one molecule for every 3 bases, since it is unlikely that AAG binding sites can 
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overlap to the extent they do on duplex DNA because there is only a single strand that 





Figure 2.9. E125Q AAG binding to single stranded DNA oligonucleotides. Experiments were 
performed with both damaged and undamaged single stranded DNA. Both 10 nM ( ) and 100 
nM () ss εA 25mer as well as 10 nM () and 100 nM () ss T 25mer were mixed with E125Q 
AAG. The x-axis was converted to equivalents of E125Q AAG that were added by dividing 
[AAG] by [DNA] used in the experiment. This allows for an easier comparison between the 
different experiments. (A) The anisotropy shows a similar behavior for both of the single-
stranded DNA oligonucleotides. Much greater concentrations of AAG are required to saturate the 
signal than is seen with duplex DNA. This indicates that AAG binds at a much higher density to 
single-stranded DNA oligonucleotides than duplex oligonucleotides. (B) The normalized FAM 
fluorescence intensity is also shown. Data shown is from single experiments. 
 







 These values were obtained by dividing the number of bases in the DNA oligonucleotide by the 
number of AAG molecules that are bound to that DNA. They are upper limits because the 
number of AAG molecules that we get from the experiments are only lower limits. 
DNA Type Bases per AAG Molecule
a 
Double-Stranded ≤ 6-8 
Single-Stranded ≤ 3 
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Model for AAG Binding 
 Our findings are summarized in Table 2.4. When DNA is free in solution (no 
AAG molecules bound) there is a low level of εA fluorescence quenching, no FAM 
quenching and low anisotropy values. When a single AAG is bound to an εA containing 
DNA, it is bound at the specific site which leads to high εA fluorescence quenching, no 
FAM quenching and an intermediate anisotropy value. As nonspecifically bound AAG 
molecules bind to the DNA (> 1 AAG bound), there is no further quenching of εA 
fluorescence. FAM fluorescence shows a high level of quenching and the anisotropy is 
also high. 
Table 2.4. Model for multiple AAG binding. 
 
 
   
# AAG 
molecules bound 
0 1 >1 
εA quenching low high no further 
FAM quenching none none high 
anisotropy low intermediate high 
 
Implications 
Complications of Multiple Protein Binding on the Binding Assay 
 One of the major implications of the findings presented above is that DNA 
binding proteins can bind multiple molecules to short DNA oligonucleotides. Proteins 
that behave in this manner make it difficult to distinguish between specific and 
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nonspecific binding using an assay such as fluorescence anisotropy. Fluorescence 
anisotropy measurements are still very useful for measuring binding to DNA when the 
protein binds in a 1:1 ratio to that DNA. It is important to know if a protein binds in a 1:1 
ratio or >1:1 ratio to DNA before trying to study binding by using fluorescence 
anisotropy. Interestingly, some specificity is seen with AAG binding to εA·T DNA, 
which means that equilibrium binding can be measured at low concentrations of DNA. In 
this case, however, fluorescence anisotropy is not sensitive enough for these 
measurements. 
High Density Binding of Other DNA Repair Proteins 
 Since DNA repair enzymes are expected to be able to bind nonspecifically to 
DNA, this high density binding may be a more common phenomenon than previously 
thought. If this is the case, there could be a more general problem with this method for 
other DNA binding proteins. Already shown above are two DNA repair enzymes that 
bind at high density to DNA, AAG and AlkA. There is evidence in the literature that 
other DNA binding proteins exhibit similar behavior. AlkD, another glycosylase, has 
been shown to take high concentrations (~10:1 AlkD: 25mer DNA) of protein to saturate 
an anisotropy signal (26). This indicates, as seen in the experiments above, that multiple 
AlkD proteins are binding to a single DNA. Another example is O
6
-alkylguanine DNA 
alkyltransferase (AGT), another DNA repair protein, has been shown to bind with high 
density (every ~4 base pairs) to DNA with analytical ultracentrifugation techniques (27). 
Probably the most well known example of DNA repair proteins binding at high density to 
DNA is the RecA family of proteins (including Rad51). These proteins coat both single- 
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and double-stranded DNA, which helps it perform its role in homologous recombination 
(25). 
Biological Implications of High Density Binding by AAG 
 It is unclear whether the high density of AAG binding to DNA has any 
physiological significance. A single AAG molecule can perform its glycosylase activity, 
as seen in multiple turnover assays (5, 13, 28). Also, single turnover kinetics show that 
the specifically bound proteins are not affected by nonspecifically bound proteins. This is 
shown by single turnover experiments done at 1:1 AAG: DNA having exactly the same 
rate constant as those done with much greater than 1:1 AAG: DNA (5, 10, 13, 28). It is 
possible that AAG may have some other biological function, such as protecting DNA or 
regulating transcription, which relies on high density binding to DNA. More work is 
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Chapter 3  
Kinetic Mechanism for the Flipping and Excision of 1, N6-




The nucleobases of DNA are susceptible to spontaneous chemical modification, 
including oxidation and alkylation. Failure to repair the resulting DNA lesions can result 
in mutations or in some cases cell death. The majority of simple base lesions are repaired 
via the base excision repair (BER) pathway (1). This pathway is initiated by a DNA 
repair glycosylase that is responsible for finding the damaged site and catalyzing the 
hydrolysis of the N-glycosidic bond. In the case of a monofunctional DNA glycosylase, 
this results in the release of the lesioned base and the formation of an abasic site in the 
DNA. The abasic site is further processed to nick the DNA backbone and remove the 
abasic sugar residue. Repair synthesis uses the intact strand as a template to ensure 
incorporation of the correct nucleotide and the nick is ultimately sealed by DNA ligase. 
The human enzyme, alkyladenine DNA glycosylase (AAG), is responsible for 
repairing a diverse set of alkylated and oxidized purines, including purines alkylated at 
the N7 and N3 positions, and the deaminated purines hypoxanthine (Hx) and oxanine [(2, 
3) and references therein]. Chemical structures of damaged and undamaged adenine bases 
are shown in Scheme 3.1. AAG also recognizes the bulkier alkylation adduct, 1,N
6
-
                                                 
1
 Reproduced with permission from Wolfe, A. E., and O'Brien, P. J. (2009) Kinetic 
mechanism for the flipping and excision of 1,N(6)-ethenoadenine by human alkyladenine 




ethenoadenosine (A) that can be formed from lipid peroxidation products and exposure 
to exogenous agents such as urethane and vinyl chloride (4, 5). This lesion is highly 
mutagenic in mammalian cells and leads to misincorporation of all possible nucleotides if 
it is replicated prior to repair (6, 7).  
 
Scheme 3.1  
AAG is the only known human glycosylase that catalyzes the excision of εA, but 
an alternative direct reversal pathway has recently been discovered in which εA can be 
directly oxidized to restore the adenine base by AlkB family members (8). This backup 
pathway may account for the observation that mice lacking AAG remain viable (9, 10). 
Nevertheless, mice lacking AAG have decreased rates of repair of εA and are unable to 
tolerate the burden of increased levels of DNA alkylation (11, 12). 
Structural and biochemical studies have provided considerable insight into the 
mechanism by which AAG recognizes and excises damaged bases and have suggested 
the minimal mechanism that is illustrated in Figure 3.1. Given the low frequency with 
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which sites of DNA damage occur, initial binding is most likely to occur at an 
undamaged site. AAG uses nonspecific binding interactions to scan DNA in the search 
for sites of damage (13). Once a damaged nucleotide is encountered, it must be flipped 
out of the duplex by 180 into the enzyme active site where lesion recognition and N-
glycosidic bond hydrolysis can occur (14-16). The excised base is released and the abasic 
nucleotide must disengage from the active site in the reverse of the flipping step. The 
nonspecifically bound AAG is able to diffuse away along the duplex in search of 
additional sites of damage and eventually can be released into solution. The rates of DNA 
binding and nucleotide flipping have not previously been measured for AAG, but are 
critical to understanding how the enzyme recognizes a wide variety of damaged 
nucleotides.  
 
Figure 3.1. Minimal mechanism for AAG-catalyzed nucleotide flipping and base excision. AAG 
(crescent) binds nonspecifically to DNA and rapidly slides in search of DNA damage. Once a 
lesion (filled rectangle) is encountered in an initial damage recognition complex it can be flipped 
out into the active site to form the specific recognition complex. In this specific complex the 
DNA is bent, the damaged nucleotide is flipped out by 180
o
, and Y162 (red circle) is intercalated 
into the DNA to take the place of the extrahelical lesion (15, 16). From this specific complex, 
AAG catalyzes hydrolysis of the N-glycosidic bond (kchem). The lesion base is subsequently 
released (kA release). The abasic product is an inhibitor of AAG, so presumably the sugar can be 
stably bound in a flipped out conformation analogous to the abasic pyrrolidine conformation 
observed by x-ray crystallography (15). Dissociation of AAG from the abasic product requires 
rotation of the abasic sugar back into the duplex (kunflip). From the less tightly bound complex, 




Several previous studies have used intrinsic protein fluorescence or the incorporation of 
fluorescent reporter groups into DNA in order to investigate the kinetics of DNA binding 
and nucleotide flipping by other families of DNA glycosylases (17-22). Together with 
studies of other DNA modifying enzymes, these studies have begun to address the 
fundamental, common features of nucleotide flipping enzymes (14). 
There is, however, circumstantial evidence that the requirement for nucleotide 
flipping provides a barrier to the excision of damaged bases by AAG (2, 23, 24). For 
example, the rate of excision of a given lesion paired with different opposing bases is 
inversely proportional to the base pairing stability [e.g., 7-methylguanine (7mG) is 
excised from a 7mG•T mismatch 50-fold faster than it is removed from a stable 7mG•C 
pair]. Since AAG does not make specific contacts with the opposing base, this 
observation is best explained by an AAG complex in which the lesion can still hydrogen 
bond with the opposing base (2). In addition, rates of repair vary widely for a given lesion 
base pair in different local sequence contexts (25). The effect of sequence context is most 
pronounced for excision of Hx (25, 26). For example, rates of excision of Hx from 
different regions of a polyA tract vary by almost two orders of magnitude (26). An early 
report mentioned that excision of εA is also sensitive to its position in a polyA tract (27), 
but subsequent studies found little or no sequence context effects for the excision of εA 
by AAG (25, 26). We were interested in learning whether nucleotide flipping is rapid, as 
has been observed for other DNA glycosylases (17, 19-22), or whether the flipping step 
might be significantly slower than the base excision step. 
Since εA is known to be fluorescent and very sensitive to its local environment 
(28), we investigated the possibility of directly monitoring the dynamics for DNA 
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binding and nucleotide flipping for this biologically relevant DNA adduct. We combined 
single turnover and multiple turnover glycosylase assays with stopped-flow fluorescence 
measurements to characterize the kinetic mechanism for AAG-catalyzed excision of εA. 
We show that AAG binding to the DNA is fast compared to the other steps and that 
binding is reversible. We present evidence that nucleotide flipping is rapid and highly 
favorable and that the excised lesion is rapidly released. These fast conformational 
changes, with relatively slow base excision are integral to the ability of AAG to 
discriminate between damaged and undamaged nucleotides. 
 
Materials and Methods 
Purification of Human Recombinant Protein 
The catalytic domain of human AAG that lacks the first 79 amino acids was 
expressed in E. coli and purified as previously described (29). The concentration of active 
AAG was determined by burst analysis, using an inosine-containing oligonucleotide 
substrate, as previously described (13, 30).  
Synthesis and Purification of Oligodeoxynucleotides 
The 25mer oligonucleotides or the constituent phosphoramidites were obtained 
from commercial sources and contained a central lesion that was placed opposite of a T. 
The sequences are given in Scheme 3.2. Oligonucleotides containing only normal 
deoxynucleotides or deoxyinosine were synthesized and deprotected with standard 
phosphoramidite chemistry, whereas those containing a single εA lesion were synthesized 
and deprotected using Ultra-Mild chemistry according to the supplier’s 
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recommendations. The εA-containing oligonucleotides were either synthesized by the 
W.M. Keck Facility at Yale University or the phosphoramidite was obtained from Glen 
Research and incorporated using an ABI 394 DNA synthesizer. The oligonucleotides  
TEC     5’-CGATAGCATCCTECCTTCTCTCCAT 
       3’-GCTATCGTAGGATGGAAGAGAGGTA 
 
AEA    5’-CGATAGCATCAAEAATTCTCTCCAT 
       3’-GCTATCGTAGTTTTTAAGAGAGGTA 
Scheme 3.2 
were desalted using Sephadex G-25 and purified using denaturing polyacrylamide gel 
electrophoresis as previously described (13). Oligonucleotides for gel-based assays were 
labeled on the lesion containing strands with a 5’-fluorescein (6-fam) label. The 
concentrations of the single stranded oligonucleotides were determined from the 
absorbance at 260 nm, using the calculated extinction coefficients for all oligonucleotides 
except those containing εA. For εA containing oligonucleotides, the extinction coefficient 





 to account for the weaker absorbance of εA as compared to A 
(31). The lesion-containing oligonucleotides were annealed with a 1.1-fold excess of the 
complement by heating to 90°C and cooling slowly to 4°C.  
Steady-State Fluorescence Measurements 
Fluorescence emission spectra were collected with a PTI QuantaMaster 
fluorometer controlled by FeliX software. For εA fluorescence, an excitation wavelength 
of 320 nm (6 nm band-pass) was used and the total fluorescence was measured at 
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emission wavelengths from 350-500 nm (6 nm band-pass). Samples (200 µL) of 400 nM 
εA-containing DNA were prepared in the standard buffer (50 mM NaMES, pH 6.5, 100 
mM NaCl, 1 mM EDTA, 1 mM DTT) and spectra were recorded at 25°C. To determine 
the steady-state fluorescence of εA-containing DNA bound to AAG, the spectra were 
recorded within 1 minute. No significant excision of εA occurs during this time. 
Single Turnover Excision of εA Monitored by Fluorescence 
Since εA is strongly quenched in duplex DNA and when bound to AAG, we were 
able to follow the release of εA into solution by the increase in fluorescence. Single 
turnover glycosylase assays were performed in the standard buffer at 25°C with 400 nM 
DNA duplex and 1.2–2.4 μM AAG. A full emission spectrum was recorded at various 
times between 2 and 120 minutes. The greatest change in fluorescence occurred at 410 
nm; therefore this wavelength was chosen to follow the release of εA into solution. The 
fluorescence at 410 nm was used to determine the fraction of εA product (Fraction 
Product = (Ft-F0)/Fmax; Ft is the fluorescence at time = t, F0 is the initial fluorescence at 
time = 0 and Fmax is the maximal fluorescence change). This normalization gives fraction 
product values between 0 and 1. These data were fit by a single exponential equation 
using nonlinear least squares regression with Kaleidagraph (Synergy Software), in which 
kobs is the rate constant, t is the time, and A is the amplitude (Equation 3.1). The single 
turnover rate constant was determined at saturating concentration of AAG and this was 
confirmed by the observation of the same rate constant at two different concentrations of 
AAG (Figure 3.2). Under these conditions, the observed rate constant is equal to the 





Fractionproduct  A(1 e
kobst )     (Equation 3.1) 
 
Figure 3.2. Confirmation that the maximal single turnover excision rate was determined. 
Identical rate constants were obtained (kmax = 0.037 min
-1
) for reaction with –TEC- (100 nM) and 
either 200 nM (red circles) or 400 nM (blue squares) AAG. The fraction abasic DNA product was 
determined from the gel-based glycosylase assay and the lines indicate the best fit of a single 
exponential equation (Equation 3.1).  
 
 Glycosylase Activity Assay 
We also measured single turnover glycosylase activity with the standard 
glycosylase activity assay that utilizes abasic site cleavage by NaOH followed by DNA 
separation on a denaturing PAGE gel (13, 29). Fluorescein labeled DNA substrates (20-
100 nM) were prepared in the standard buffer with 0.1 mg/mL BSA added. The reactions 
were initiated with the addition of 100-400 nM AAG and incubated at 25°C. At various 
time points, a sample from the reaction was removed and quenched in 2 equivalents of 
0.3 M NaOH, giving a final hydroxide concentration of 0.2 M. The abasic sites were 
cleaved by heating at 70°C for 10 minutes. Samples were mixed with an equal volume of 
formamide/EDTA loading buffer and heated 3 minutes at 70°C before loading onto a 12-
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15% polyacrylamide gel. Gels were scanned with a Typhoon Imager (GE Healthcare) to 
detect the fluorescein label by exciting at 488 nm and measuring emission with a 
520BP40 filter. The gel bands were quantified using ImageQuant TL (GE Healthcare). 
The data was converted to fraction product [Fraction Product = product / (product + 
substrate)] and then fit by a single exponential (Equation 3.1). The observed rate constant 
for the single turnover reaction was independent of the concentration of AAG, indicating 
that the maximal rate constant was measured (kobs = kmax; Figure 3.2).  
Stopped-Flow Kinetics 
Pre-steady state kinetic experiments were performed on a Hi-Tech SF-61DSX2, 
controlled by Kinetic Studio (TgK Scientific). The fluorescence of εA was measured 
using an excitation wavelength of 320 nm and a WG360 long-pass emission filter. The 
concentrations that are given for enzyme and substrate are those obtained after mixing 
equal volumes in the stopped-flow. The reactions were followed for either 2 or 10 
seconds to monitor initial binding events occurring before the base excision step could 
occur. Binding of AAG to εA containing DNA was measured by mixing a constant 
concentration of DNA with increasing concentrations of AAG. Experiments were 
performed with either 0.15 µM or 0.5 µM concentration of DNA after mixing, and final 
concentrations of AAG up to 8 µM. Three traces were averaged together at each 
concentration, which revealed two phases. The traces were fit by a double exponential 
(Equation 3.2), in which F is εA fluorescence as a function of time, C is the fluorescence 
of the free DNA, Y is the change in fluorescence of the first intermediate, and Z is the 
change in fluorescence of the second intermediate.  The observed rate constants for the 







k 2,obst )     (Equation 3.2) 
It is possible to relate these observed rate constants to the microscopic rate 
constants in Scheme 3.3, with a bimolecular binding step followed by a unimolecular 
conformational change that occurs prior to the chemical step.  
 
Scheme 3.3  
The initial binding step appears to be reversible (see below), and therefore the 
observed rate constant is given by the sum of the association and dissociation steps in 
Scheme 3.3 (k1, obs = [AAG] k1 + k-1). It should be noted that this equation applies when 
[E]>>[S]. Under our conditions the enzyme was in only modest excess (2–7-fold). 
Nevertheless, the resulting values of k1 are in reasonably good agreement with the values 
measured by mixing equimolar solutions of enzyme and substrate (see below). We 
suggest that the unimolecular step corresponds to nucleotide flipping. Since this is an 
approach to equilibrium, the observed rate constant is equal to the sum of the rate 
constants for the forward and reverse flipping steps (k2, obs = k2 + k-2). Substrate 
dissociation experiments, measured by pulse-chase suggest that the value of k2 is much 
greater than k-2, indicating that k2, obs is approximately equal to k2, the microscopic rate 
constant for flipping.  
Rapid binding and weak fluorescence made it difficult to fully analyze the binding 
step under conditions of true excess of enzyme over substrate, therefore we also 
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performed mixing experiments in which a 1:1 ratio of [DNA]: [AAG] was maintained 
(0.15-1.5 µM). Three traces were averaged together at each concentration and they were 
fit by equation 3.3, where F is εA fluorescence as a function of time, C is the 
fluorescence of the free DNA, Y and Z are the change in fluorescence of the first and 
second intermediates relative to the free DNA, E0 is the starting concentration of AAG 
and DNA ([AAG] = [DNA]), k1 is the bimolecular rate constant for binding, k2, obs is the 
observed unimolecular rate constant for the subsequent flipping step, and t is the time. 
The expression that corresponds to the initial binding step in equation 3.3 has been 
previously described (32), and the origin of this equation is provided in the Appendix. 
  











k 2,obst )     (Equation 3.3) 
The fits to equation 3.3 were excellent in all cases and the observed rate constants 
that were obtained were in good agreement with the values of k1 and k2, obs that were 
obtained from the binding experiments in which AAG was in excess over DNA.  
Pulse-Chase Assay 
To measure the rate constant for AAG dissociating from the εA-containing DNA 
substrate, pulse-chase experiments were performed. These assays were done at 25°C in 
the standard buffer, except that the concentration of NaCl was varied and 0.1 mg/mL 
BSA was added. In 20 µL reactions, 100 nM fluorescein-labeled –TEC– DNA was mixed 
with 200 nM AAG for 20 seconds. A chase of 20 μM unlabeled –TEC– DNA was then 
mixed in. If AAG dissociates from the labeled DNA before the chemical cleavage step 
and then binds to the unlabeled DNA, less of the reaction will occur during the single 
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turnover part of the curve as compared to the same experiment without chase. Samples 
were taken at the specified times and quenched as described above. The samples were run 
on sequencing gels and the fraction product was calculated as described above. It was 
expected that the production of product would follow a simple exponential (Equation 
3.1), but under the conditions employed a very slow steady-state reaction was also 
observed. This was accounted for by Equation 3.4, in which the burst phase gives the 
amplitude (A) and an observed rate constant (kobs). The steady-state phase is dependent 
upon the steady-state rate constant (kcat), the concentration of enzyme (E), and the total 
concentration of labeled and unlabeled DNA substrate.  
  (Equation 3.4) 
According to the two step binding mechanism described in Scheme 3.3, two 
different partitioning equations can be written (33). Since all labeled substrate is initially 
bound, the fraction of product formed is given by fraction that goes on to react. This is 
indicated by Equation 3.5, in which A is the burst amplitude (the fraction of product 
cleaved in the burst phase of the experiment), kmax is the maximal single turnover rate 
constant for formation of product, and koff,obs is the macroscopic rate constant for 
dissociation from the stable flipped out complex. This expression can be rearranged to 
solve for the desired dissociation rate constant (Equation 3.6). Similarly, for branched 
pathways, the observed rate constant for the burst phase of the pulse-chase experiment is 
given by the sum of the rate constants for the competing pathways, formation of product 
is given by kmax and the macroscopic dissociation of substrate is designated koff, obs 


















 kmax        (Equation 3.6) 
  

kobs  koff,obs  kmax        (Equation 3.7) 
  

koff,obs  kobs  kmax        (Equation 3.8) 
Control reactions in which no chase was added provided the single turnover rate 
constant, kmax, and confirmed that these concentrations of AAG were saturating. From 
these values, the dissociation rate constant, koff, for AAG dissociating from εA-DNA was 
calculated by two different methods (Equations 3.6 and 3.8). Both methods gave 
essentially identical values for koff, obs and we report the average of the results obtained 
with both methods. 
Since the εA-DNA binds in two steps, the observed rate constant for dissociation 
of substrate (koff, obs) could be limited by the unflipping rate (k-2) or dissociation from 
nonspecific DNA (k-1). According to Scheme 3.3, and assuming that the flipped out 
complex is stable (i.e., k2 >> k-2), this observed dissociation rate can be expressed in 
terms of the microscopic rate constants [Equation 3.9; (33)]. Stopped-flow fluorescence 
suggests that dissociation from the initial AAG•DNA complex is rapid (k-1 ~30 s
-1
) 
relative to the forward flipping rate constant k2 = 2.6 s
-1
, and therefore the observed rate 
constant for substrate dissociation from the εA-DNA•AAG complex is approximately 













      (Equation 3.9) 
The pulse chase experiment was performed at high and low ionic strength by 
varying the concentration of sodium chloride from 50-300 mM. It has previously been 
shown that the rate constant for dissociation of the abasic DNA product increases as ionic 
strength is increased, presumably due to the disruption of electrostatic interactions at 
higher ionic strength (13, 34).  
Steady-State Excision of Hypoxanthine 
The maximal rate constant for excision of Hx (kcat) was determined for a 25 base 
pair oligonucleotide of the same sequence as the –TEC– DNA, but with deoxyinosine in 
place of the A. Under multiple turnover conditions, the rate-limiting step is dissociation 
of the abasic DNA [kcat = koff for abasic DNA; (34, 35)]. The experiments were 
performed at 25°C and in the standard buffer that also contained 0.1 mg/mL BSA. In 20 
µL reactions, 2 μM fluorescein labeled DNA was mixed with 20-50 nM AAG. Aliquots 
were removed at specific times and quenched as described above. These samples were 
diluted 10-fold into formamide/EDTA buffer and run on sequencing gels and quantified 
as described above. The fraction product was converted into the concentration of product 
([P] = fraction product  [DNA]). The initial velocity (Vi) was determined from a linear 
fit to the time-dependent formation of abasic product over the first 15% of the reaction. 
The value of kcat was calculated by dividing the velocity by the concentration of enzyme 




Fluorescence of εA is a Sensitive Reporter of the Lesion Environment 
The feasibility of using the intrinsic fluorescence of εA to monitor the individual 
steps of the AAG-catalyzed reaction was evaluated for two different 25 base pair 
oligonucleotides that each contained a central εA lesion. These two sequences will be 
referred to by the central sequence of the lesion-containing strand (Scheme 3.2). 
Excitation of both single stranded oligonucleotides at 320 nm gave a broad fluorescence 
emission peak centered at 410 nm (Figure 3.3A). The oligonucleotide of sequence –TEC- 
gave ~4-fold lower fluorescence than free εA, consistent with quenching of εA 
fluorescence even in single-strand DNA. Surprisingly, the oligonucleotide of sequence –
AEA- yielded much higher fluorescence, essentially identical to that of free εA. When a 
1.1-fold excess of the appropriate complement was annealed to these sequences, then the 
fluorescence emission was decreased by a factor of ~1.7-fold for –TEC- and 1.4-fold for 
–AEA- (Table 3.1). This is consistent with increased quenching due to enhanced base 
stacking interactions in duplex DNA. Addition of a higher concentration of complement 
did not further quench the fluorescence (data not shown).  
It is not clear why these two sequence contexts show such different quenching, 
but it is possible that the lack of nearby G nucleotides can account for the high 
fluorescence of –AEA-. A previous study of charge transfer between εA and normal 
bases reported that G is the most efficient quencher of εA, with only modest quenching 






Figure 3.3. Fluorescence of εA-containing DNA in single-strand, duplex, and in complex with 
AAG. Fluorescence emission spectra of 400 nM DNA were collected with excitation at 320 nm, 
as described in the Materials and Methods. (A) Both single-strand () and duplex –TEC– () are 
compared to single-strand () and duplex (■) –AEA– DNA. The εA in both sequences is more 
fluorescent in the single-strand and becomes quenched in the duplex. (B) Fluorescence emission 
spectra were collected in the presence of saturating concentration of AAG and compared to the 
spectra in the absence of AAG. The –TEC– duplex DNA exhibited very similar fluorescence in 
the absence () or presence () of AAG. In contrast, the –AEA– duplex DNA, which was 
strongly fluorescent in the absence of protein (■), was strongly quenched in the presence of AAG 
(□). The spectra were taken within 1 minute of AAG addition (1 M), during which time 
negligible excision can occur. 
concentration of oligonucleotides was incorrect could be ruled out by measuring the 




Since the AAG-catalyzed excision of εA is relatively slow under these conditions, 
it was possible to examine the effect of AAG binding to each oligonucleotide in a 
conventional fluorometer. The addition of one equivalent of AAG resulted in a dramatic 
5-fold decrease in the fluorescence of the –AEA– substrate, whereas that of the –TEC– 
                                                 
2
 Samples that contained 400 nM of either –TEC– or –AEA– duplex (determined using the UV-
absorbance and the calculated extinction coefficients) gave identical fluorescence emission 
spectra upon the complete hydrolysis by AAG (Figure 3.4A and B). This eliminates the trivial 
possibility that different amounts of DNA were compared. Therefore, we conclude that the –
AEA– sequence has significantly higher fluorescence than the –TEC– sequence in both single-

















































substrate was only slightly quenched (Figure 3.3B). Addition of more than one equivalent 
of AAG had no further effect on either spectrum (data not shown). The two 
oligonucleotides exhibit almost identical fluorescence emission when they are bound to 
AAG (Figure 3.3B). This observation strongly suggests that the εA is in a similar 
environment in both complexes, most likely flipped out of the duplex and bound in the 
AAG active site. Crystal structures of the AAG•εA-DNA complex indicate potential 
quenching interactions between the εA lesion and active site tyrosines Y127 and Y159 
(16). The environment of the protein active site is more strongly quenching than the–
AEA– sequence context, but very similar to that of the –TEC– sequence context. The 
strong quenching of both complexes relative to free εA in solution suggested that a 
continuous fluorescence-based assay could be used to follow the εA excision activity of 
AAG. 
Single Turnover Glycosylase Activity of AAG Monitored by εA Fluorescence and by 
Formation of the Abasic DNA Product  
Hydrolysis of the N-glycosidic bond by AAG results in the formation of an abasic 
site and a free base (Figure 3.1). Early assays of AAG employed alkylated genomic DNA 
and relied upon directly detecting the released base by HPLC or scintillation counting 
(37, 38). More commonly, gel-based discontinuous assays are used to detect the 
formation of a single strand break (27, 29, 39). These assays can employ either a 
fluorescent or radioactive label, and the abasic product is converted into a single-strand 
nick by hydrolyzing the abasic site at alkaline pH. In contrast, the fluorescent properties 
of εA provide the opportunity for a continuous glycosylase assay. We directly 
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Table 3.1. Sequence-dependent changes in εA fluorescence and rate constants for binding 
and excision by AAG
a
 
 Sequence Context 
 –TEC– –AEA– 
∆F hybridization
b
 1.7 1.4 
∆F binding
b







 2.1 ± 0.9  10
8































 5.7 ± 0.3  10
-4
















Values are reported at 25 
o
C in a buffer containing 50 mM NaMES, pH 6.5, 100 mM NaCl, 1 
mM EDTA, and 1mM DTT. 
b
εA fluorescence was determined with 400 nM εA-containing DNA 
and a 3 mm pathlength cuvet with excitation at 320 nm and emission at 410 nm. The ∆F 
hybridization is the ratio of the fluorescence of single-stranded DNA divided by the fluorescence 
of the double-stranded DNA (Figure 3.3A). The ∆F binding to AAG is the ratio of the 
fluorescence of the double-stranded DNA divided by the fluorescence of the saturated 
AAG•DNA complex (Figure 3.3B). 
c
The association rate constant (kon) was determined from the 
data in Figure 3.7. dThe dissociation rate constant (koff) was determined from the data in Figure 
3.6. 
e
The rate constant for flipping was determined by stopped-flow (Figure 3.8). As discussed in 
the text, the second phase of the change in εA fluorescence is simply kflip, since kunflip is much 
slower than kflip. Given the similar rate constants for the two sequences, we assumed that the 
observed rate constant for the –AEA– sequence is also the flipping rate constant. 
f
The reverse rate 
constant for flipping (kunflip; Figure 3.1), is determined from the macroscopic rate constant for 
dissociation of the substrate (Figure 3.9), as described in the text. gThe equilibrium for 
nucleotide flipping is defined as the ratio of the forward rate constant for flipping measured by 
stopped-flow and the reverse rate constant for flipping (Kflip = k2/k-2; Scheme 3.3). 
h
The rate for 
the chemical step is simply the rate constant for the single turnover excision of εA (Figure 3.4D), 
since the equilibrium constant for base flipping is highly favorable and the rate constant for 
flipping is much faster than the hydrolysis step. The values shown are determined from εA 




 was determined from the 
gel-based assay. 
i
The dissociation constant for the nonspecific AAG•DNA complex is given by 
the ratio of the off and on rates measured by stopped-flow (Kd
ns
 = koff/kon). 
j
The dissociation 







ND, not determined. 
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compared the fluorescence-based assay to the traditional gel-based assay to determine 
whether εA release is fast or slow and to evaluate the potential of using fluorescence to 
monitor the glycosylase activity of AAG.  
Under single turnover conditions, with enzyme in excess over the DNA substrate, 
AAG was incubated with oligonucleotide –TEC– and fluorescence emission spectra were 
collected at the indicated intervals (Figure 3.4A). The εA fluorescence (max = 410 nm) 
increased over time, reaching a maximum value at ~2 hours. Under identical conditions, a 
fluorescein-labeled oligonucleotide of the identical sequence (–TEC–) was incubated 
with AAG and aliquots were quenched in sodium hydroxide and analyzed by denaturing 
polyacrylamide gel electrophoresis (Figure 3.4C). The change in fluorescence was 
converted into the fraction of εA released into solution and the fraction of abasic product 
was quantified from the gel and these data were plotted together (Figure 3.4D; See 
Materials and Methods for details). The reaction progress curves were readily fit by a 
single exponential, and the observed rate constants for εA release (kmax
eA
 = 0.036 ± 0.002 
min
-1
) and for abasic site formation (kmax = 0.038 ± 0.002 min
-1
) were identical within 
error. A simultaneous fit to both reaction progress curves gave the same value (kmax = 
0.038 min
-1
; Figure 3.4D). Since the detection of the abasic DNA product by sodium 
hydroxide quench/hydrolysis does not require dissociation of the εA, the observation of 
the same rate constant for release of εA into solution is most simply consistent with rate-











Figure 3.4. Comparison of εA release and N-glycosidic bond cleavage from single turnover 
assays. Fluorescence emission spectra monitoring the increase in fluorescence that is observed 
upon single turnover excision of A from (A) –TEC– and (B) –AEA– DNA catalyzed by AAG. 
The spectra for samples containing 400 nM duplex DNA were collected prior to the addition of 
protein (), and within 1 minute of the addition of 1.2 M AAG (). Additional spectra were 
collected after 3 (▲), 6 (), 12 (■), 30 (), 60 (♦), 90 () and 120 (▼) minutes. The high 
fluorescence of the –AEA– substrate is strongly quenched upon binding to AAG. Representative 
experiments are shown, but duplicate reactions gave essentially identical results, and the rate of 
reaction was independent of [AAG]. (C) The gel-based glycosylase assay relies on selective 
hydroxide-catalyzed cleavage of abasic sites and the different mobility of intact substrate and 
nicked product to monitor formation of the abasic DNA product. A representative denaturing 
polyacrylamide gel shows the separation of the fluorescein-labeled substrate (25-mer) and 
product (12-mer) and a time course for the formation of the abasic DNA product. The first lane 
shows a no enzyme control. The small amount of nicked DNA (~4%) results from nonenzymatic 
ring-opening and depurination during synthesis, purification, and the hydroxide heating step. The 
next 5 lanes indicate samples taken from a reaction containing 100 nM –TEC– DNA and 200 nM 
AAG that were quenched 2–120 minutes after the initiation of the reaction by the addition of 
AAG. (D) Quantification of the above results indicates that both assays are limited by a common 
step, presumably N-glycosidic bond cleavage. The fraction product was calculated from the εA 
fluorescence assay for –TEC– () and –AEA– () as well as the gel based excision assay for –
TEC– (♦). The error bars indicate the standard deviation for 2-5 independent determinations. The 
reaction curves for –TEC– monitored by both assays are fit by a single exponential (Equation 3.1; 
kmax = 0.038 min
-1































































The single turnover assay for release of εA was also performed for the –AEA– 
DNA under the same conditions that were used for the –TEC– DNA (Figure 3.4B). The 
initial fluorescence of this DNA in the absence of AAG is much higher than for the –
TEC– sequence, but upon the addition of AAG the fluorescence was strongly quenched. 
The observed increase in fluorescence was of similar magnitude to that which was 
observed for the –TEC– substrate, and a similar single turnover rate constant was 




 These data indicate that once AAG 
is bound, it shows very similar efficiency of excising εA from these two different 
sequence contexts. 
Association and Nucleotide Flipping Monitored by Stopped-Flow Fluorescence 
The quenching of εA fluorescence observed upon binding of AAG to εA-
containing DNA suggested that εA would be a useful reporter to monitor association of 
AAG and DNA. Therefore, we performed stopped-flow fluorescence experiments to 
monitor the time-dependent changes in εA fluorescence. Two phases were observed 
when excess AAG was mixed with 500 nM –TEC– DNA, both of which occur well 
before the base excision step (Figure 3.5A).  
In the first 100 ms, there is a transient increase in fluorescence and this is 
followed by a decrease in fluorescence that is complete within a few seconds after 
mixing. The fluorescent traces were best fit by a double exponential equation, indicating 
a two-step model for DNA binding (Scheme 3.3). As increasing concentrations of AAG 
were mixed with a fixed concentration of –TEC– DNA, the rate of the first phase 
increased (Figure 3.5A and Figure 3.6). However, at concentrations above 1 μM AAG this 
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initial phase occurred in the mixing time of the stopped-flow. The dependence of the first 
phase of the fluorescence change upon the concentration of reactants indicates that a 




Figure 3.5. Stopped-flow fluorescence measurements of the binding of A-DNA to AAG with 
excess protein. Representative data is shown from experiments in which a fixed concentration of 
DNA was mixed with increasing concentrations of AAG. Samples were excited at 320 nm and 
emission was collected with a 360 nm long-pass filter (See Materials and Methods for details). 
Several individual reactions were monitored at each concentration of AAG, and the traces shown 
are the averages of all reactions. Since the fluorescence changes were superimposed at the 
different concentrations of AAG, the traces are offset for clarity. (A) The binding of 0.5 μM –
TEC– duplex DNA by 0.5 (bottom), 1, 2, 4, and 8 μM AAG (top). (B) The binding of 0.15 μM –
AEA– duplex DNA by 0.5 (bottom), 1, and 2 μM (top) AAG. The lines indicate the best fits of 
equation 3.2 to each binding reaction.  
 
It should be noted that the fit of the two concentrations of AAG with the –TEC– 
substrate in Figure 3.6 is tenuous, however it was possible to measure binding over a 
wider concentration range for the more highly fluorescent –AEA– DNA. 
Since initial binding is expected to be away from the site of damage, and the 
bimolecular step gives a detectable change in fluorescence, we interpret this behavior to 
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reflect a rate-limiting binding step with no change in fluorescence, followed by a rapid 
sliding step that results in the formation of a complex with a detectable change in 
fluorescence. We infer that the scanning step is too fast to be directly observed in our 
experiments (Figure 3.1), with a lower limit of 250 s
-1
 indicated by the data in Figure 3.6. 
 
Figure 3.6. Determination of the forward and reverse rate constants for the initial binding of AAG 
to εA-DNA. The observed rate constant for DNA binding (k1, obs) is from the first phase of the 
binding reactions shown in Figure 3.5. The average and standard deviations are shown for 2-4 
determinations. The dissociation rate constant for the initial AAG•DNA complex can be 
determined from the y-intercept of this plot (k1, obs = k-1 + k1 [AAG]; Scheme 3.3). For –AEA– 
DNA (■), the best linear fit (solid line) gives an intercept of 48 s
-1







 (k1). This second order rate constant is identical to the value determined from equimolar 
binding experiments (Table 3.1 and Figure 3.8). For –TEC– DNA (), only two concentrations 
of protein gave reliable data due to the weak fluorescence and more rapid binding. A linear fit 
(dotted line) of the two data points that were obtained gives an intercept of 22 s
-1













 (dashed line), the value that 
was independently determined from equimolar binding reactions (Table 3.1 and Figure 3.8), an 
intercept of 43 s
-1
 was obtained. We take the average (33 ± 15 s
-1
) as a rough estimate for the k-1 
value for this substrate.  
The increased fluorescence of this early intermediate is likely to reflect partial unstacking 
of the A lesion during the initial damage recognition by AAG. The second phase of the 
binding reaction was insensitive to the concentration of AAG and we interpret this to be 
the flipping of the εA lesion into the AAG active site, where it is strongly quenched. For 
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the –TEC– substrate, this AAG-bound complex happens to have very similar 
fluorescence to that of free DNA duplex in solution (Figure 3.3B). 
We performed analogous stopped-flow binding experiments with the –AEA– 
substrate (Figure 3.5B). Binding of AAG to this sequence appears to be superficially 
different, without a transient increase in fluorescence, but is also best explained by a two-
step binding mechanism. For this substrate, the fluorescence is initially high in the free 
DNA, is partially quenched in the first intermediate, and is more strongly quenched in the 
fully flipped complex. These traces could not be fit well by a single exponential (data not 
shown), but were well fit by a double exponential (Figure 3.5B). As the concentration of 
AAG was increased at a fixed concentration of DNA, the rate for the first exponential 
was proportional to the amount of AAG, and the second phase was not (Figure 3.5 and 
Figure 3.6 and data not shown). The fits to the second phase of the reaction were excellent 
in all cases, but the fits to the first phase were more variable due to the very fast binding. 
As the fluorescence of A is relatively weak, it was not possible to use significantly lower 
concentrations of DNA that would have allowed more accurate determination of the 
association and dissociation rate constants of this fast binding reaction.  
Therefore, the stopped-flow experiments were repeated with equimolar amounts 
of enzyme and substrate, with concentrations ranging from 0.15–1.5 µM (Figure 3.7). 
This causes the binding reaction to slow as free ligand is consumed, allowing a time-
dependent change in fluorescence to be observed even at high initial concentrations 
Similar experiments have been used to study binding reactions of equimolar protein 
fragments (40, 41). Since the unimolecular flipping step also gives an observed 
fluorescence change, a second exponential term is also required (Equation 3.3). The 
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 for both sequences (Figure 3.8A; Table 3.1). Experiments carried out 
across a 10-fold concentration range gave the same rate constant. This better-defined 
value for the association rate constant (k1; Scheme 3.3) was used to fit the data from the 
concentration dependence of AAG when protein was in excess and provide an estimate of 
the dissociation rate constant (k-1 ≈ 30 s
-1




Figure 3.7. Kinetics of DNA binding and nucleotide flipping, determined by stopped-flow 
fluorescence at equimolar concentrations of AAG and DNA. AAG was rapidly mixed with an 
equimolar solution of –TEC– (A) or –AEA– (B) DNA to yield final concentrations after mixing 
of 0.15 (bottom) to 1.5 M (top). Each trace is the average of 3 independent binding reactions, 
and the lines indicate the best fits of equation 3.3. For the –TEC– substrate the raw data is plotted, 
indicating the increased signal observed at higher concentrations of DNA, but for the –AEA– 
substrate the larger fluorescence change required that the gain be adjusted between different 
concentrations of DNA and therefore the individual traces are arbitrarily offset. 
The second phase of the binding reaction followed a single exponential and the 
same rate constant was observed across the concentration range tested (Figure 3.8B). The 
observed rate constant for flipping is an approach to equilibrium and therefore is the sum 






Figure 3.8. The rate constants for binding and nucleotide flipping by AAG in two different 
sequence contexts. The observed rate constants for –TEC– DNA (, solid line) and –AEA– DNA 
(■, dashed line) were taken from the fits of equation 3.3 to the data for equimolar binding 
reactions (Figure 3.7). (A) The observed bimolecular rate constant for the initial binding of AAG 






; Table 3.1). According to the simple 
two-step binding mechanism depicted in Scheme 3.3, this observed rate constant is simply k1, the 
microscopic rate constant for binding. (B) The observed rate constant for the second step is 
independent of concentration, and yields an average value of 4.3 s
-1
 for the –AEA– sequence 
context compared to a value of 2.6 s
-1
 for the –TEC– sequence context. According to Scheme 3.3, 
this observed rate constant is the sum of the forward and reverse rate constants for flipping (k2, obs 
= k2 + k-2). Additional experiments described below indicate that the equilibrium constant for 
flipping is highly favorable (k2 >> k-2), and therefore the observed rate constant for flipping is 
simply the forward rate constant for flipping (see text for additional discussion). 
Below we describe a pulse-chase experiment that resolves this ambiguity by 
establishing that the reverse rate constant for flipping (k-2) is much slower than the rate 
constant measured by the stopped-flow fluorescence, such that the observed rate constant 
is simply the forward rate constant for flipping (k2, obs = kflip). The nucleotide flipping step 
(kflip) is significantly faster for the –AEA– sequence than for the –TEC– sequence (4.3 ± 
0.4 s
-1
 versus 2.6 ± 0.1 s
-1
). The difference in the rates of flipping in two different 
sequence contexts may reflect subtle differences in how AAG engages these different 
DNA molecules or sequence-dependent changes in the intrinsic motions of DNA. 
Regardless of the origin of the differences between the two sequence contexts that were 
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examined, these data establish that the flipping step is much faster than the N-glycosidic 
bond hydrolysis step (Table 3.1).  
A Pulse-Chase Assay to Determine the Macroscopic Rate of Substrate Dissociation  
In order to gain further insight into the two-step binding mechanism of AAG, we 
also examined the dissociation of substrate from AAG by a pulse-chase assay (30, 33). In 
this experiment, fluorescein-labeled –TEC– substrate was briefly incubated with AAG (t1 
= 20 s) to give it time to bind, and then was chased with a 100-fold excess of –TEC– 
substrate lacking the fluorescein label (Figure 3.9A). Samples were taken over the normal 
single turnover time course to evaluate the partitioning of a bound E•S complex between 
N-glycosidic bond hydrolysis and dissociation. Figure 3.9B shows the εA-excision 
reaction in the presence and absence of chase. The addition of chase caused a decrease in 
the fraction of substrate hydrolyzed and an increase in the observed rate constant, as 
expected if the forward rate constant for reaction is similar to the rate constant for 
dissociation (see Methods for details). Under these conditions (I = 120 mM), the 
macroscopic rate constant for dissociation is 0.12 ± 0.02 min
-1
 (Table 3.1). Since the 
equilibrium for bound A-DNA lies towards the fully flipped out complex, either k-1 or k-
2 could in principle limit the observed rate constant for dissociation. However, the rapidly 
reversible initial binding step exhibits a much faster rate constant (k-1 ~ 30 s
-1
; Figure 3.6). 
Therefore, the observed rate constant for the dissociation of the substrate that was 
measured by the pulse-chase assay is simply the unflipping rate constant (k-2; Scheme 










Figure 3.9. Pulse-chase experiment to measure the macroscopic dissociation rates for A-
containing DNA substrate. (A) The experimental design is indicated. Fluorescein (FAM)-labeled 
DNA (100 nM –TEC–) was mixed with excess AAG (200 nM) for 20 seconds (incubation time, 
t1) then 20 μM unlabeled –TEC– DNA was added as a chase. The reactions were quenched at the 
indicated time points (t2), and the fraction of abasic DNA product determined by alkaline 
hydrolysis and gel electrophoresis (See Materials and Methods for additional details). (B) Single 
turnover excision of εA from –TEC– DNA by AAG in the absence () or presence (■) of chase 
under the standard reaction conditions.  In the absence of chase, the line indicates the best fit to a 
single exponential (Equation 3.1). In the presence of chase, the line indicates the best fit of an 
exponential burst followed by a slow steady-state reaction (Equation 3.4). This gives a 
macroscopic dissociation rate constant of 0.12 ± 0.01 min
-1
. (C) Comparison of pulse chase 
experiments performed at concentrations of sodium chloride. The data from experiments at () 
70 mM, (■) 120 mM and (▲) 320 mM ionic strength were fit by equation 3.4 (lines). Analysis of 
the observed rate constant and the endpoint gave essentially identical macroscopic rate constants 
and the average and standard deviation of duplicate reactions determined by both methods 
yielded macroscopic dissociation rate constants of 0.08 ± 0.005, 0.12 ± 0.01, and 0.35 ± 0.05  
min
-1
, respectively for 70, 120, and 320 mM ionic strength.  
It has previously been observed that the rate of dissociation of AAG from its 
abasic DNA product is extremely sensitive to the ionic strength, with a 25-fold increase 
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in the rate of dissociation between 40 and 120 mM ionic strength (34). This effect of 
ionic strength is presumably due to electrostatic interactions between the positively 
charged protein and the negatively charged DNA that become weaker at higher ionic 
strength. In order to evaluate whether the unflipping rate constant or the DNA 
dissociation rate constant is rate-limiting, we varied the ionic strength with the 
expectation that the dissociation step should exhibit a large ionic strength effect. The 
results of pulse-chase experiments carried out at 70, 120, and 320 mM ionic strength are 
shown in Figure 3.9C. The pulse-chase experiment revealed a small decrease in 
amplitude and concomitant increase in the observed rate constant as the ionic strength is 
increased. Control reactions established that the single turnover rate constant in the 
absence of chase is independent of ionic strength under these conditions (data not 
shown), consistent with previous results (13, 34). Therefore, the modest ~4-fold change 
in the observed substrate dissociation rate constant between 70 and 320 mM is further 
evidence that k-2 and not k-1 is rate limiting for dissociation of A-DNA. This moderate 
sensitivity to ionic strength indicates either a small effect of ionic strength on the flipping 
step, or a small contribution from the rate constant for dissociation from nonspecific 
DNA. 
Rate Constant for Dissociation of the Abasic DNA Product  
We measured the rate of dissociation of the abasic DNA product to compare it to 
the rate of εA product release. The steady-state reaction of AAG with –TEC- substrate 
gave a kcat value that is essentially identical to the single turnover rate constant under 
these reaction conditions (data not shown), suggesting that the very slow rate of 
hydrolysis of the N-glycosidic bond is rate limiting for multiple turnover excision of εA 
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at high ionic strength. Since AAG shows much faster rates of excision of Hx from inosine 
lesions, we measured the kcat value for multiple turnover on an inosine-containing 
substrate, in Figure 3.10.  
 
Figure 3.10. Multiple turnover excision of hypoxanthine by AAG. Under the standard 
conditions, the rate-limiting step is dissociation of the abasic DNA product. Shown are the fits to 
the first 10% of the reaction for 2 μM –TEC- DNA with 20 nM (●) and 50 nM (■) AAG. These 
data gave a rate constant for abasic DNA dissociation of 0.24 ± 0.06 min
-1
. This is similar to the 
value of 0.73 min
-1
 that was measured at 37 
o
C and pH 7.0 (34). 
It has previously been shown that AAG exhibits burst kinetics for the excision of 
Hx and that the steady-state rate constant, kcat, reflects the rate of dissociation of the 
abasic DNA product (34). We determined that the rate constant for the dissociation of 
abasic DNA is 0.24 min
-1
 under these reaction conditions, ~6-fold faster than the rate 
constant for N-glycosidic bond cleavage (Scheme 3.4). This is only slightly faster than 





suggesting that the abasic DNA product is also likely to be stably bound in an 
extrahelical conformation. 
Discussion 
Minimal Kinetic and Thermodynamic Mechanism for Excision of εA  
We have used the intrinsic fluorescence of the εA lesion to establish the kinetic 
mechanism for the AAG-catalyzed recognition and excision of this alkylated base. The 
fluorescence of εA is highly sensitive to the local environment of the lesion and it proved 
to be a sensitive reporter of three distinct steps in the AAG-catalyzed reaction; initial 
lesion recognition, nucleotide flipping, and εA product release. The rate constants that 
were determined from changes in εA fluorescence are in excellent agreement with the 
rate constants measured by the traditional glycosylase assay that detects the abasic DNA 
product, indicating that A release is fast and that fluorescence provides a useful assay of 
AAG activity.  
The kinetic mechanism for recognition and excision of εA is depicted for the –
TEC– sequence in Scheme 3.4.  
 
Scheme 3.4. 
Initial binding is near the diffusion-limited rate and is rapidly reversible. Given 
that a detectable change in εA fluorescence occurs as a bimolecular reaction, we cannot 
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distinguish between the possibilities that initial binding by AAG occurs solely at the εA 
lesion or that AAG binds at another site but rapidly transfers to the εA lesion. We favor 
the latter model, since it is known that AAG can use nonspecific DNA binding 
interactions to translocate between sites (13). Since these data require the scanning 
step(s) to be very rapid (kscan; Figure 3.1), this step is not shown in Scheme 3.4. This 
initial recognition complex is rapidly reversible, with a dissociation rate constant of 
~1800 min
-1
. This indicates a relatively weak complex for initial nonspecific DNA 
binding and we calculate a dissociation constant of ~150 nM from these data (Kd
ns
; Table 
3.1). Occasionally, AAG catalyzes full nucleotide flipping with a rate constant of ~160 
min
-1
. The extrahelical complex is highly stable, with a calculated equilibrium constant of 
~1300 for the flipping step, and this tight binding decreases the dissociation constant for 
binding of AAG to an εA lesion by several orders of magnitude to approximately 100 pM 
(Table 3.1). This exceptionally tight binding to the εA site is consistent with previous 
reports of sub-nanomolar binding by AAG under different experimental conditions (2, 
42). The crystal structure of AAG bound to εA reveals a snug fit of the εA lesion into the 
AAG pocket where it accepts a hydrogen bond from the backbone amide of His136 (16). 
This interaction with His136 can also account for the discrimination against normal 
adenosine nucleotides (2, 16). Tight binding of the damaged nucleotide by AAG could 
protect it from DNA-templated activities such as transcription and replication. 
Despite the rapid and highly favorable flipping of the εA lesion, AAG is limited 
by a very slow rate of N-glycosidic bond cleavage, such that the specific recognition 
complex is only partially committed to base excision. Release of εA, measured by the 
increased fluorescence of the free base, is much faster than the rate of N-glycosidic bond 
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cleavage measured by formation of the abasic DNA product. At 25 
o
C, this rate constant 
for N-glycosidic bond cleavage is 0.04 min
-1
, 5-fold slower than is observed at 37 
o
C (2). 
Under these conditions, base excision is also slower than release of the abasic DNA 
product, such that no burst is observed (Table 3.1 and data not shown). Since N-
glycosidic bond cleavage for inosine is much faster than for εA, the slow release of the 
abasic DNA product is rate-limiting for the multiple turnover reaction of AAG with 
inosine and other rapidly hydrolyzed lesions (34). Rate-limiting release of the abasic 
DNA product provides the opportunity for coordination of the steps of the BER pathway. 
It has previously been shown that the slow rate of dissociation of AAG from its abasic 
DNA product can be stimulated by APE1, the enzyme that acts next in the base excision 
repair pathway (34, 35, 43).  
Recognition of εA in a PolyA-Tract  
Earlier studies had investigated the AAG-catalyzed excision of εA from different 
sequence contexts. One study reported that the excision of εA by AAG is sensitive to the 
sequence context and that an A lesion in the center of a polyA-tract is a particularly poor 
substrate for AAG (27). In contrast, a later report examined a number of similar sequence 
contexts and found that there did not appear to be significant effects of sequence context 
on the excision of εA (26). However, Hx-containing substrates show large sequence 
context effects hinting at a fundamental difference between the recognition of A and Hx 
(25, 26, 43, 44). In this study we performed a more thorough kinetic characterization to 




Overall, the steps of εA recognition and excision by AAG are very similar for the 
two DNA substrates (Table 3.1). The rate constants for DNA binding and excision are 
identical within error, but the observed rate constant for flipping is ~1.7-fold higher for 
the polyA-tract sequence. Although this is a small change, the rate constant for flipping is 
independent of DNA and enzyme concentration and is sufficiently well defined by the 
stopped-flow data to indicate a real difference. This difference in rate could be due to 
changes in either the structure or the dynamics of different DNA sequences. 
Nevertheless, since nucleotide flipping is rapid and highly favorable, the difference in 
flipping rate does not translate into a significant difference in the rate of εA excision from 
these two sequences. The minimal kinetic and thermodynamic framework (Scheme 3.3) 
provides a molecular explanation for why AAG does not exhibit strong sequence-
dependent differences in the rates of excision of A, but does show strong effects for 
other lesions. By extension, it is very likely that other lesions that are recognized by 
AAG, such as the deaminated base lesion Hx, are not stably flipped and thus changes in 
stacking interactions have a larger effect on the flipping equilibrium and on the observed 
rates of excision (2, 25). 
Comparison of AAG to Other Glycosylases  
There are several distinct structural and evolutionary families of DNA repair 
glycosylases (45, 46). These enzymes differ in their chemical mechanisms and in the 
identity of the lesions that they recognize, but nonetheless all recognize damaged bases 
and catalyze the cleavage of the N-glycosidic bond (47, 48). The observation that all of 
these enzymes that recognize nucleotides in duplex DNA catalyze nucleotide flipping 
attests to the requirement of the enzyme to gain access to the N-glycosidic bond that is 
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occluded in duplex DNA (26). Fluorescence methods have been used to study the DNA 
binding and nucleotide flipping steps for a few of these enzymes and the results from the 
literature are summarized in Table 3.2. Since each of these enzymes belongs to a different  












Narrow substrate range      
  UDG      UDG 2’-fluoroU•G 1260 38 33 N/Ac (17) 
  U•A 1100 370 3 58 (18) 















  T4 Pdg      HhH D•2APf ≥300 NDe ≥10 N/Ac (20) 
  Ogg1      HhH 8-oxo-G•C 13 1 10 0.07 (21) 
Broad substrate range      
  Fpg      Fpg 8-oxo-G•C 12 12 1  0.16 (22) 
  AAG      AAG εA•T 3 0.002 1300 0.0006 This study 
a
HhH, helix-hairpin-helix superfamily. UDG (uracil DNA glycosylase), Fpg 
(formamidopyrimidine DNA glycosylase), and AAG are the founding members of distinct 
enzyme superfamilies. T4 Pdg, pyrimidine dimer DNA glycosylase from phage T4, and Ogg1, 
human 8-oxoguanine DNA glycosylase. 
b
kchem is the rate constant for the first chemical step, 
hydrolysis of the N-glycosidic bond.
 c
N/A, not applicable. 
d
Rate constants for binding of UDG to 
single-stranded DNA with two different sequence contexts. It should be noted that a very 
different process of nucleotide selection is expected in single strand and duplex DNA, but the 
values are included here because they are remarkably similar to the values that were 
independently measured for the enzyme binding to duplex DNA. 
e
ND, not determined. 
f
The 
D•2AP (tetrahydrofuran•2-aminopurine) pair mimics an abasic site product. 
superfamily and therefore evolved independently, it is interesting to consider whether 
there are common functional constraints that have dictated the kinetic mechanisms of 
these enzymes (46, 49, 50). One crude classification that can be used is whether the 
enzyme exhibits a narrow substrate range (recognizing one or a few structurally related 
lesions) or whether it exhibits a broad substrate range (recognizing a variety of 
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structurally diverse lesions). The rate constant for flipping varies across two orders of 
magnitude from 3 s
-1
 to more than 1000 s
-1
. With these limited data, it seems that the 
enzymes with a narrow substrate range exhibit faster flipping rates than those with a 
broader substrate range. This could be related to the difficulty of optimizing the rate of 
flipping of distinct lesions by the enzymes with a broad substrate range, or it could 
simply reflect the slow rate of N-glycosidic bond cleavage since the flipping step is still 
much faster than the hydrolysis step. Indeed, the nucleotide flipping step is much faster 
than the N-glycosidic bond cleavage step for all of these enzymes (Table 3.2). 
 The equilibrium constant for flipping is close to unity for formamidopyrimidine 
DNA glycosylase (Fpg), the only enzyme with a broad substrate range that has been 
previously characterized. It makes sense that an enzyme that can accommodate 
structurally diverse lesions might not be able to hold all lesions tightly. In contrast, the 
enzymes that recognize a narrow range of substrates all exhibit favorable equilibrium 
constants for flipping of ≥10. Interestingly, AAG has an exceptionally broad range of 
substrates and yet also has the most highly favorable equilibrium constant for flipping 
that has been measured. Biochemical evidence suggests that εA is unique among the 
well-characterized AAG substrates, because other lesions such as 7-methylguanosine and 
inosine appear to have unfavorable equilibrium constants for flipping by AAG (2, 25). 
Implications of Multi-stage Recognition for the Biological Specificity of AAG  
The findings presented above have several implications for the initiation of base 
excision repair by AAG. The most obvious is that the kinetic mechanism is optimized for 
specificity rather than speed. The vast excess of undamaged nucleotides in DNA provides 
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a challenge to an enzyme that must recognize a broad range of structurally distinct 
substrates. Two-step binding is rapid and readily reversible at each step, which provides 
multiple opportunities for discrimination between damaged and undamaged bases. The 
multiplicative effect of multi-stage recognition allows even small differences between 
normal and damaged bases to be magnified to achieve the specificity that is required to 
recognize rare lesions that can occur throughout the genome. 
Once the lesion is flipped, rate-limiting N-glycosidic bond cleavage allows for 
additional discrimination between damaged and undamaged nucleotides. Pyrimidines are 
selected against by the catalytic mechanism, which is optimized for purine nucleotides, 
and A and G are selected against by steric clashes with their exocyclic amino groups (2, 
16, 29, 51). Since alkylated nucleotides that bear positive charge are activated for N-
glycosidic bond cleavage, some alkylated purines are removed at biologically relevant 
levels despite the relatively poor rate enhancement (52, 53). 
We propose that the highly favorable equilibrium constant for the flipping of εA 
by AAG is the exception that proves the rule. The opposing base effects that have 
previously been noted strongly suggest that the equilibrium constant for flipping 
methylated and deaminated purines is unfavorable (2, 25). In spite of this unfavorable 
equilibrium, many of these other lesions are excised by AAG more rapidly than the A 
lesion is excised. The favorable equilibrium constant for εA helps to compensate for the 
very slow rate of base excision. If εA is not repaired, it is highly mutagenic, and therefore 
it must be removed from the genome. However, human cells have a relatively long cell 
cycle and this provides a wide window of time during which repair can be performed 
prior to DNA replication. Therefore DNA repair enzymes can afford to sacrifice speed 
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(overall rate of reaction) for increased selectivity (ability to recognize subtle 
perturbations in the chemical structure of DNA). AAG is able to effectively locate rare 
sites of damage that are hidden in the sea of undamaged DNA by employing multiple 
DNA binding steps that are rapidly reversible and each provide specificity towards DNA 
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Chapter 4  
Substitution of Active Site Tyrosines with Tryptophans Alters 





Human alkyladenine DNA glycosylase (AAG) is responsible for recognizing a 
wide variety of structurally diverse deaminated and alkylated purine lesions (1-2). It 
initiates the base excision DNA repair pathway by catalyzing the hydrolysis of the N-
glycosidic bond and releasing the lesion base. Subsequent action of an abasic-site specific 
endonuclease, a 5’-deoxyribose phosphate lyase, a DNA repair polymerase, and a DNA 
ligase are required to restore the correct DNA sequence, using the intact strand as a 
template. Crystal structures of AAG in complex with DNA revealed that this enzyme 
uses nucleotide flipping to gain access to the N-glycosidic bond of a damaged nucleotide 
(3-4). We have recently used the intrinsic fluorescence of εA to characterize the minimal 
kinetic mechanism for the recognition, flipping, and excision of this lesion by wildtype 
AAG (5). The minimal mechanism from this work is summarized in Scheme 4.1. Rapid 
mixing experiments indicated that an initial recognition complex rapidly and reversibly 
formed in which the εA lesion was partially unstacked. We hypothesized that further 
changes in the fluorescence of the εA lesion was indicative of the flipping step in which 
the εA was captured in the active site of AAG. In order to test this hypothesis, we sought 
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to observe conformational changes in the protein directly. Similar approaches have been 
very informative for other DNA repair glycosylases (6-9). 
 
Scheme 4.1. 
The catalytic domain of AAG contains 3 tryptophan and 6 tyrosine residues. The 
3 tryptophan residues are all found near the surface on the opposite side of the protein 
from the active site and the DNA binding interface, suggesting that their environment 
would not change upon DNA binding. Five of the tyrosine residues line either the binding 
pocket or the DNA-protein interface, but tyrosine absorbance is very close to the 
absorbance of the DNA and it seemed unlikely that they would serve as useful reporters. 
Therefore, we introduced tryptophan residues into the binding pocket of AAG, 
substituting either Y127 or Y159, the two tyrosine residues that sandwich the bound 
lesion in the crystal structures (3-4). The conformation of Y127 is stacked over the εA 
lesion, whereas the Y159 phenolic side chain makes a T-shaped interaction with this 
lesion (Figure 4.1). Comprehensive analysis of aromatic stacking interactions in protein 
structures suggests that T-type interactions are very common and presumably contribute 
similar favorable interaction energies (10). It has been suggested that a tyrosine to 
tryptophan mutation should be relatively conservative (11). However these two positions 
are invariantly found to be tyrosine in AAG homologs in organisms ranging from 




Figure 4.1. Active site contacts with the flipped out εA from the published crystal structure of 
AAG bound to εA-DNA. The coordinates are from 1EWN (4) and the figure was rendered with 
Pymol. For clarity, only the immediate residues surrounding the εA base are shown.  
Substitution of conserved tyrosine residues with tryptophan at position 127 and 
159 in the AAG active site had minimal effects on the excision of εA. However, there 
were much larger effects on the rate and equilibrium constant for nucleotide flipping. 
These are consistent with the simple model that bulky tryptophan residues in the active 
site destabilize the flipped out conformation and accelerate the rate constant for 
unflipping. Although flipping is perturbed in these mutants, they follow the same 
mechanism as the wildtype enzyme with formation of two distinct intermediates prior to 
N-glycosidic bond cleavage. Identical rate constants were observed from time-dependent 
changes in both εA and tryptophan fluorescence, demonstrating that there are already 
changes in the active site environment prior to full nucleotide flipping and that the most 
strongly quenched intermediate that was previously observed is indeed the extrahelical 




Materials and Methods 
Purification of Wildtype and Mutant AAG  
The catalytic domain of human AAG that lacks the first 79 amino acids was 
expressed in E. coli and purified as previously described (13). The Y127W and Y159W 
mutants were constructed by site directed mutagenesis and purified using the same 
protocol (13). The concentration of AAG was determined by fluorescent titration of εA -
DNA, as described below, and the concentration was found to be within 2-fold of the 
concentration determined from the calculated extinction coefficient of the wildtype or 
mutant proteins.  
Synthesis and Purification of Oligodeoxynucleotides  
The 25mer oligonucleotides were synthesized by Integrated DNA Technologies 
or by the W.M. Keck Facility at Yale University, shown in Scheme 4.2.  
TEC     5’-CGATAGCATCCTECCTTCTCTCCAT 
       3’-GCTATCGTAGGATGGAAGAGAGGTA 
 
AEA    5’-CGATAGCATCAAEAATTCTCTCCAT 
       3’-GCTATCGTAGTTTTTAAGAGAGGTA 
Scheme 4.2 
The oligonucleotides were desalted using Sephadex G-25 and purified using denaturing 
polyacrylamide gel electrophoresis as previously described (14). Oligonucleotides for 
gel-based assays were labeled on the lesion containing strand with a 5’-fluorescein (6-
fam) label. The concentrations of the single stranded oligonucleotides were determined 
from the absorbance at 260 nm, using the calculated extinction coefficients for all 
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oligonucleotides except those containing εA. For εA containing oligonucleotides, the 
extinction coefficient was calculated for the same sequence with an A in place of the εA 




 to account for the weaker absorbance of εA as 
compared to A (15). The lesion-containing oligonucleotides were annealed with a 1.1-
fold excess of the complement by heating to 90°C and cooling slowly to 4°C.  
Steady-State Fluorescence Measurements  
Fluorescence emission spectra were collected with a PTI QuantaMaster 
fluorometer controlled by FeliX software. For εA fluorescence, an excitation wavelength 
of 320 nm (6 nm band-pass) was used and the total fluorescence was measured at 
emission wavelengths from 350-500 nm (6 nm band-pass). Samples (200 µL) of 400 nM 
εA-containing DNA were prepared in the standard buffer (50 mM NaMES, pH 6.5, 100 
mM NaCl, 1 mM EDTA, 1 mM DTT) and spectra were recorded at 25°C. To determine 
the steady-state fluorescence of εA-containing DNA bound to AAG, the spectra were 
recorded within 1 minute. No significant excision of εA occurs during this time. The data 
were fit to a quadratic equation assuming tight binding by AAG (~2 nM Kd) (16-17). 
Single Turnover Excision of εA Monitored by Fluorescence  
Experiments with mutant and wildtype AAG were performed as previously 
described (5). In all cases, the same rate constant was measured at two different 
concentrations of AAG. This demonstrates that AAG was saturating and that the maximal 
single turnover rate constant was determined.  
Since εA is strongly quenched in duplex DNA and when bound to AAG, we were 
able to follow the release of εA into solution by the increase in fluorescence. Single 
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turnover glycosylase assays were performed in the standard buffer at 25°C with 400 nM 
DNA duplex and 1.2–2.4 μM AAG. A full emission spectrum was recorded at various 
times between 2 and 120 minutes. The greatest change in fluorescence occurred at 410 
nm. Therefore this wavelength was chosen to follow the release of εA into solution. The 
fluorescence at 410 nm was used to determine the fraction of εA product (Fraction 
Product = (Ft-F0)/Fmax; Ft is the fluorescence at time = t, F0 is the initial fluorescence at 
time = 0 and Fmax is the maximal fluorescence change). This normalization gives fraction 
product values between 0 and 1. These data were fit by a single exponential equation 
using nonlinear least squares regression with Kaleidagraph (Synergy Software), in which 
kobs is the rate constant, t is the time, and A is the amplitude (Equation 4.1). The single 
turnover rate constant was determined at saturating concentration of AAG and this was 
confirmed by the observation of the same rate constant at two different concentrations of 
AAG. Under these conditions, the observed rate constant is equal to the maximal single 
turnover rate constant (kobs = kmax).  
)e1A(productFraction
tkobs      (4.1) 
Stopped-Flow Kinetics  
Pre-steady state kinetic experiments were performed on a Hi-Tech SF-61DSX2, 
controlled by Kinetic Studio (TgK Scientific). The fluorescence of εA was measured 
using an excitation wavelength of 320 nm and a WG360 long-pass emission filter as 
previously described (5). The fluorescence of tryptophan was measured using an 
excitation wavelength of 295 nm and a 330BP20 band-pass emission filter. Due to the 
weak fluorescence of εA and tryptophan and the fast association rate constant, we 
monitored binding with equimolar concentrations of εA-DNA and protein. Under these 
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conditions, the time-dependent changes in fluorescence could be fit by Equation 4.2, in 
which F is εA fluorescence as a function of time, C is the fluorescence of the free DNA, 
Y and Z are the change in fluorescence of the first and second intermediates relative to 
the free DNA, E0 is the starting concentration of AAG and DNA ([AAG] = [DNA]), k1 is 
the bimolecular rate constant for binding, k2, obs is the observed unimolecular rate constant 
for the subsequent flipping step, and t is the time (5, 18). 
  











k 2,obst )     (4.2) 
Several different concentrations between 0.15 and 1.5 μM (all concentrations are 
given after mixing) gave the same rate constants, confirming that the concentration 
chosen was saturating for mutant and wildtype proteins. At least three traces were 
averaged together for each concentration in two independent experiments, and the 
averaged data were fit by Equation 4.2 using Kaleidagraph. 
Pulse-Chase Assay to Measure Substrate Dissociation  
The macroscopic rate constant for dissociation of wildtype and mutant AAG from 
εA-containing DNA was measured by pulse-chase in the standard reaction buffer as 
previously described for wildtype AAG (5). Briefly, 50 nM fluorescein-labeled TEC 
DNA was mixed with 100 nM AAG for 20 seconds, a chase of 200 μM unlabeled TEC 
DNA was added. At various time points, a sample from the reaction was removed and 
quenched in 2 volume equivalents of 0.3 M NaOH, giving a final hydroxide 
concentration of 0.2 M. The abasic sites were cleaved by heating at 70°C for 10 minutes. 
Samples were mixed with an equal volume of formamide/EDTA loading buffer and 
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heated 3 minutes at 70°C before loading onto a 12-15% polyacrylamide gel. Gels were 
scanned with a Typhoon Imager (GE Healthcare) to detect the fluorescein label by 
exciting at 488 nm and measuring emission with a 520BP40 filter. The gel bands were 
quantified using ImageQuant TL (GE Healthcare). The data were converted to fraction 
product [Fraction Product = product / (product + substrate)]. 
Base excision catalyzed by AAG results in fluorescein-labeled product, whereas 
dissociation releases uncleaved fluorescein-labeled substrate. The partitioning between 
hydrolysis and dissociation are can be determined from both the exponential rate constant 
and by the change in burst amplitude (Equation 4.3 and 4.4). These assays were done at 
25°C in the standard buffer, except that the concentration of NaCl was varied and 0.1 
mg/mL BSA was added. In 20 µL reactions, 100 nM fluorescein labeled –TEC– DNA 
was mixed with 200 nM AAG for 20 seconds. A chase of 20 μM unlabeled –TEC– DNA 
was then mixed in. If AAG dissociates from the labeled DNA before the chemical 
cleavage step and then binds to the unlabeled DNA, less of the reaction will occur during 
the single turnover part of the curve as compared to the same experiment without chase. 
Samples were taken at the specified times and quenched as described above. The samples 
were run on sequencing gels and the fraction product was calculated as described above. 
It was expected that the production of product would follow a simple exponential 
(Equation 4.1), but under the conditions employed a very slow steady-state reaction was 
also observed. This was accounted for by Equation 4.4, in which the burst phase gives the 
amplitude (A) and an observed rate constant (kobs). The steady-state phase is dependent 
upon the steady-state rate constant (kcat), the concentration of enzyme (E), and the total 
concentration of labeled and unlabeled DNA substrate.  
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   (4.4) 
 
Scheme 4.3. 
According to the two-step binding mechanism described in Scheme 4.3, two 
different partitioning equations can be written (19). Since all labeled substrate is initially 
bound, the fraction of product formed is given by fraction that goes on to react. This is 
indicated by Equation 4.5, in which A is the burst amplitude (the fraction of product 
cleaved in the burst phase of the experiment), kmax is the maximal single turnover rate 
constant for formation of product, and koff,obs is the macroscopic rate constant for 
dissociation from the stable flipped complex. This expression can be rearranged to solve 
for the desired dissociation rate constant (Equation 4.6). Similarly, for branched 
pathways, the observed rate constant for the burst phase of the pulse-chase experiment is 
given by the sum of the rate constants for the competing pathways, formation of product 
is given by kmax and the macroscopic dissociation of substrate is designated koff, obs 












 kmax         (4.6) 
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koff,obs  kobs  kmax         (4.8) 
Control reactions in which no chase was added provided the single turnover rate 
constant, kmax, and confirmed that these concentrations of AAG were saturating. From 
these values, the dissociation rate constant, koff, for AAG dissociating from εA-DNA was 
calculated by two different methods (Equation 4.6 and 4.8). Both methods gave 
essentially identical values for koff, obs and we report the average of the results obtained 
with both methods. 
Since the εA-containing DNA binds in two steps, the observed rate constant for 
dissociation of substrate (koff, obs) could be limited by the unflipping rate (k-2) or 
dissociation from nonspecific DNA (k-1) or both. According to Scheme 4.3, and assuming 
that the flipped complex is stable (i.e., k2 >> k-2), this observed dissociation rate can be 
expressed in terms of the microscopic rate constants [Equation 4.9; (19)]. Stopped-flow 
fluorescence experiments suggests that dissociation from the initial AAG•DNA complex 
is rapid (k-1 ~30 s
-1
) relative to the forward flipping rate constant k2 = 2.6 s
-1
, and 
therefore the observed rate constant for substrate dissociation from the εA-DNA•AAG 











       (4.9) 
The pulse chase experiment was performed at high and low ionic strength by 
varying the concentration of sodium chloride from 50-300 mM. It has previously been 
shown that the rate constant for dissociation of the abasic DNA product increases as ionic 
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strength is increased, presumably due to the disruption of electrostatic interactions at 
higher ionic strength (14, 20).  
Results 
Tryptophan Fluorescence of Native AAG  
Since the catalytic domain of AAG (residues 80-298) has almost identical 
glycosylase activity as the full-length protein (13, 20-21), but is considerably more stable, 
we have used this construct for all of the experiments described below. In addition to 
exploring the functional contributions of the invariant tyrosine residues in the AAG 
active site, we hoped to develop fluorescent probes that could report on ligand binding 
and conformational changes. The catalytic domain of AAG contains 3 tryptophan 
residues, raising the possibility that the native protein might undergo changes in its 
intrinsic fluorescence upon binding to DNA. All 3 of these residues are located near the 
surface on the opposite side of the enzyme from the DNA binding surface that was 
identified in crystal structures (3-4). We initially tried to remove these tryptophan 
residues to simplify the fluorescence spectra when additional tryptophan residues were 
added to the protein. Although each individual tryptophan could be mutated singly to 
phenylalanine and full glycosylase activity was maintained, attempts to combine these 
into a triple mutant resulted in insoluble protein in E. coli (data not shown). Before 
embarking on more extensive mutagenesis studies, we tested whether the native protein 
would undergo any changes in tryptophan fluorescence upon binding to an εA-containing 
DNA. Whereas binding could be readily detected by changes in the εA fluorescence 
(excitation at 320 nm and emission at 400 nm), parallel experiments in which tryptophan 
fluorescence was measured gave no detectable changes in fluorescence (excitation at 295 
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nm and emission at 330 nm; data not shown). This strongly suggests that the tryptophan 
residues do not change their environment upon DNA binding and nucleotide flipping. 
These observations and the data below support our conclusion that time-dependent 
changes in the tryptophan fluorescence of mutant proteins with an additional tryptophan 
simply follow the local environment of the single tryptophan mutation in the active site 
pocket. 
Titration of AAG Mutants with εA-containing DNA  
We performed titrations with a fixed concentration of εA-containing DNA and 
increasing concentration of AAG to determine the concentration of AAG. It was 
previously shown that –AEA- DNA shows a large decrease in fluorescence upon binding 
to wildtype AAG (See Materials and Methods; (5)). The resulting change in fluorescence 
as a function of AAG concentration was consistent with a simple titration and provided 
the concentration of AAG (Figure 4.2; See Materials and Methods for details). This 
concentration of AAG mutants that was determined from these titrations was used 
throughout as the concentration of active AAG. 
Glycosylase Activity of AAG Mutants  
We next measured the single turnover glycosylase activity of the wildtype and 
mutant proteins. Since εA is strongly quenched in duplex DNA, and becomes fluorescent 
upon its release into solution, we monitored the fluorescence of εA-containing DNA 
incubated with either wildtype or mutant forms of AAG under single turnover conditions, 





Figure 4.2. Titration of εA-containing DNA to determine the concentration of AAG. Samples of 
400 nM –AEA- DNA were titrated with increasing concentration of either Y127W (squares) or 
Y159W (circles) AAG and the εA fluorescence was recorded. Each curve is an average of 3 




Figure 4.3. Single turnover excision of εA monitored by fluorescence. The reaction time-course 
for wildtype (●, solid line), Y127W (□, dashed line), and Y159W (▲, dotted line) AAG are 
shown for two different sequences, -TEC- (A) and –AEA- (B).   
93 
 
For wildtype AAG, a rate constant of 0.048 min
-1
 was obtained, similar to the 
previously reported value of 0.034 min
-1
 (5). The Y159W mutant was 2.7-fold slower 
than wildtype and the Y127W mutant was 4-fold slower (Table 4.1). These effects are 
similar to the respective 2.7-fold and 8-fold effects of these mutations on the single 
turnover excision of εA measured by abasic site formation under different reaction 
conditions (13). These are relatively modest decreases in the single turnover glycosylase 
activity, which raised the possibility that these introduced tryptophan residues could serve  
 
Table 4.1. Kinetic parameters for flipping and excision of εA by wildtype and mutant 
AAG. 
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reported in (5) 
b
These data are from the stopped-flow experiment. They are an upper limit 
because kobs = kflip + k-flip, so kobs could reflect either of the two microscopic flipping rates 
c
These 
data are from the pulse-chase experiment. They are a lower limit because all of the DNA was 
chased off during the experiment, so it cannot be lower than these values but it could be faster 
d
Kflip is calculated by dividing kflip by k-flip. It is an upper limit due to the limits on the two 
microscopic rate constants 
e
These data are from the glycosylase activity assay. They are a lower 
limit because the if kchem is the rate limiting step, this is the rate constant. However, but the 
observed rate constant could also be affected by the flipping step, which means that kchem could be 
greater than this value if the flipping step was rate limiting 
 
as useful reporters on the rates of conformational changes within the protein. For 
wildtype AAG, the maximal single turnover rate constant is likely to be N-glycosidic 
bond hydrolysis since the equilibrium constant for flipping is highly favorable. However, 
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the maximal single turnover rate constant could be limited by either the nucleotide-
flipping step or the N-glycosidic bond cleavage step for these mutants (Scheme 4.3).  
Stopped-Flow Fluorescence of εA  
To evaluate whether the Y127W or Y159W mutants alter the rate constants for 
DNA binding or nucleotide flipping, we performed rapid mixing experiments with –TEC- 
DNA. We chose to use equimolar concentrations of DNA and protein at concentrations 
far above the dissociation constant for DNA binding, since this proved to be a convenient 
way to follow the two-step binding of AAG to this DNA. We monitored the fluorescence 
changes in εA, as previously described for wildtype AAG (5), and the data are shown in 
Figure 4.4A and B. Both mutants exhibit transient increases and subsequent decreases in 
εA fluorescence similar to the two-step binding that was observed for wildtype AAG.  
For the Y127W mutant, the initial phase of the reaction that corresponds to the 
initial binding step and the observed rate constant is identical within error to the rate 
constant that was previously measured for wildtype AAG under these conditions (Table 
4.1). The second phase of the reaction corresponds to the nucleotide flipping step, and 
this occurs approximately 3-fold slower than observed for wild-type AAG. For a 
reversible reaction, this observed rate constant is equal to the sum of the rate constants for 
the forward and reverse nucleotide flipping steps. We previously established that the 
forward rate constant for flipping is much greater than the reverse rate constant for 
flipping for the wild-type AAG, so that kflip = k2, obs = 3 s
-1
(5). As the sum of the forward 
and reverse rate constants is decreased by a factor of 3, the forward rate constant for 














Figure 4.4. Stopped-flow fluorescence to measure binding and nucleotide flipping by Y127W and 
Y159W mutants of AAG. Equimolar mixtures of AAG and –TEC- DNA were mixed in the 
stopped-flow instrument and either εA fluorescence or tryptophan fluorescence was measured as 
described in the methods. (A) εA fluorescence for Y159W. (B) Tryptophan fluorescence for 




The Y159W mutant showed less εA fluorescence in the transient formation of the 
initial intermediate. This could indicate either a lower concentration of an intermediate 
that has similar fluorescent properties as wildtype, or it could indicate that this mutant has 
a more strongly quenching environment than wildtype. The first rate constant appears to 
be ~4-fold faster than was observed for the wildtype and Y127W, but this value is poorly 
defined by these data and the weak εA fluorescence precludes the direct determination of 
the binding rate constant under conditions of excess protein or excess DNA. Remarkably, 
the observed rate constant for the second phase of the reaction is more than 5-fold faster 
for the Y159W mutant than for the wildtype protein (Table 4.1).  This places an upper 
limit on the forward rate constant for flipping of 15 s
-1
, but this data does not establish 
whether this mutation increases the rate constant for nucleotide flipping. This faster 
observed rate constant could also be explained by a 6000-fold increase in the reverse rate 
constant for flipping with no change in the forward rate constant for flipping. As 
described below, additional experiments are required to resolve these ambiguities. 
Stopped-Flow Measurement of Tryptophan Fluorescence  
We also followed the fluorescence of the tryptophan during the rapid-mixing 
experiments and the results are shown in Figure 4.4C and D. Control reactions in which 
the tryptophan fluorescence was recorded for wildtype AAG that was mixed with εA-
containing DNA established that none of the three tryptophans present in AAG were 
sensitive to DNA binding (data not shown). This is consistent with the location of the 
three native tryptophan residues on the opposite surface of AAG from the DNA binding 
interface. When the Y127W and Y159W mutants were mixed with –TEC- DNA, then 
two phases of decreasing fluorescence were observed (Figure 4.4). These data were best 
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fit by the same equation that was used to monitor εA fluorescence, and yielded the same 
rate constants as were observed for εA fluorescence changes. These data reveal that 
tryptophan at position 127 and 159 in the active site pocket are sensitive to the initial 
AAG•DNA complex. This generally suggests that the protein changes its local 
conformation as fast or faster than the DNA conformational change that is monitored by 
the εA fluorescence. In the second step, these tryptophan residues are quenched in the 
flipped out complex with the same observed rate constant as the εA is quenched. The 
crystal structure of wildtype AAG bound to εA-containing DNA shows that Y127 and 
Y159 both interact with the εA base, so it is expected that W residues at these sites would 
also interact. 
 Pulse Chase Experiments to Determine the Rate of Substrate Dissociation  
We next performed pulse-chase experiments in which wildtype or mutant AAG 
proteins were initially mixed with fluorescently labeled –TEC- DNA and then chased 
with excess unlabeled –TEC- DNA (Figure 4.5). The wildtype protein gave the same 
results as previously reported, with 40% of the substrate partitioning forward to product 
and ~60% dissociating. Under these conditions, the observed rate constant is simply the 
reverse rate constant for nucleotide flipping [kobs = k-flip = 0.002 s
-1
; (5)]. In contrast, the 
addition of chase completely blocked the reaction by the Y127W and Y159W mutants 
(Figure 4.5B and C). This indicates that the rate of substrate dissociation is much faster 
than the rate of N-glycosidic bond cleavage and places a lower limit on the rate of εA 
dissociation of ~20-fold faster than the rate of N-glycosidic bond cleavage, assuming that 










Figure 4.5. Pulse-chase experiment to measure dissociation of –TEC- DNA substrate. The 
partitioning between the forward reaction (base excision) and substrate dissociation were 
measured for wildtype (A), Y127W (B), and Y159W (C) AAG. Either wildtype of mutant AAG 
was mixed with FAM-labeled –TEC- DNA in the presence (■) or absence (●) of excess unlabeled 
–TEC- DNA, as described in the Materials and Methods. Data are the average of two independent 
experiments. 
  Discussion 
Comparison of Wildtype and W Mutant AAG 
 We examined the functional consequences of mutating each of the tyrosine 
residues in the AAG active site pocket. Tryptophan was chosen as a conservative 
replacement with the intent to be able to directly monitor conformational changes and 
binding of base lesions in the active site. Although initial experiments showed robust 
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activity towards an εA lesion, a more complete analysis demonstrated that these mutants 
severely impair the equilibrium for flipping by AAG.  
Tryptophan mutations at Y159 and Y127 each have small overall effects on 
excision of εA as compared with wildtype AAG (2.7- and 4-fold, respectively). However, 
large effects from these mutations are seen when other kinetic parameters are 
investigated. For Y127W AAG, slower flipping kinetics are observed. The rate constant 
for the flipping step is decreased at least 3-fold. From the pulse-chase data, we know that 
the unflipping rate constant is increased by at least 10-fold. This leads to the equilibrium 
constant for flipping being destabilized as compared to wildtype AAG (≤ 50 compared to 
1300). Y159W AAG, on the other hand, exhibits a faster observed rate constant for the 
flipping step than wildtype AAG. This could be explained by a faster flipping rate 
constant or by a faster unflipping rate constant or some combination of the two. The 
pulse-chase data shows at least a 10-fold increase in the unflipping rate constant for this 
mutant as well. The result of the changes in these rate constants leads to destabilization of 
the equilibrium constant for flipping (≤ 470 compared to 1300 for wildtype AAG). It is 
likely that the flipping equilibrium constant is still favorable for these two mutants and 
the εA lesion since there is not a great effect on the chemical step. This is consistent with 
the idea that εA is easier to flip than many other lesions that AAG recognizes since it 
does not hydrogen bond with the opposing base.  
These experiments show that there are significant effects on the rate constants and 
equilibrium constants for flipping of εA when either active site tyrosine is mutated to 
tryptophan. These effects are seen even though εA is expected to be easy to flip due to its 
lack of base pairing with the opposing base. It is expected that experiments with the 
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mutant proteins and stably base paired lesions will show larger effects. Indeed, in 
preliminary experiments, these mutations have large effects on excision of stably paired 
lesions, such as inosine and 7-methylguanine. It is likely that the destabilization of the 
equilibrium constant for nucleotide flipping in the AAG mutants can explain why the 
excision of other lesions are more strongly influenced by these mutations. This suggests 
that these mutations will have limited utility in studying other AAG substrates in the 
future.  
Comparison of Fluorescent Signals 
Utilizing the tryptophan reporters allows the occupancy of AAG active site pocket 
to be monitored at the same time as εA fluorescence. In these experiments, the identical 
rate constants for each fluorescent signal supports the previous assignment that the 
quenching of εA fluorescence corresponds to εA flipping fully into the AAG active site 
pocket (5). The initial recognition complex also shows detectable changes in fluorescence 
of these active site tryptophan residues. This suggests that there may be conformational 
changes in AAG that accompany either a nonspecific or initial recognition complex 
which occurs before the fully flipped complex. Nevertheless, the observation that 
tryptophan and εA fluorescence are tightly correlated suggests that the intermediate seen 
in the stopped-flow experiment changes the environment of both fluorophores. This is 
likely to be due to a partially flipped complex, where the εA fluorescence is increased 
when it is no longer stacked in the DNA but not yet stacked in the active site of AAG and 
the tryptophan would be partially quenched due to either interaction with the εA or a 
change in the protein conformation that changes the environment of the tryptophan. The 
strongly correlated fluorescence signals also strengthen the previous assignment that the 
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most highly quenched intermediate is the flipped out complex. This is likely due to the 
stacking of the two fluorophores against each other in the active site, each one quenching 
the fluorescence of the other. 
Functional Insights into Active Site Tyrosines 
Substitution of tyrosine with tryptophan is expected to be a relatively conservative 
mutation, since both side chains occupy similar volumes and can make similar stacking 
interactions. However, positions 127 and 159 in homologs of human AAG are invariantly 
tyrosine. Extensive mutagenesis of AAG and selection for active site variants that 
conferred resistance to DNA alkylating agents has identified hundreds of allowed 
mutations, but no active variants at position 127 have been identified (22-23). Only two 
substitutions were observed at position 159 (N and F) in those experiments. This suggests 
that these two active site residues are important for AAG to perform its role in DNA 
repair within the cell. 
From the data above, the mutation at Y127W slows the rate of flipping. This 
could be due to the larger bulk of the tryptophan hindering flipping of εA. The unflipping 
is also increased by at least 10-fold compared to wildtype AAG, which suggests that the 
bulk of tryptophan also causes εA to be less stabile in the active site pocket.  
The mutation at Y159W appears to accelerate the rate constant for nucleotide 
flipping. This could be due to a 5-fold effect on flipping, a 6000-fold effect on unflipping, 
or a combination of increase in the two. It is not clear how replacing the tyrosine with 
tryptophan would increase the flipping rate constant, but it is likely that the unflipping 
rate constant is increased due to the extra bulk of the tryptophan in the active site that 
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would perturb the εA lesion that is bound there. It is not possible to draw further 
conclusions about which rate constant is increased unless more experiments are done. 
In order to draw more specific conclusions about the effects of the tryptophan 
mutations on the flipping and unflipping rate constants, dissociation experiments would 
need to be done to measure the rate constant for unflipping directly. In these experiments, 
the dissociation would be measured in the stopped-flow instrument utilizing a pulse-
chase type scheme to capture the protein after it dissociates from the labeled DNA. The 
experiments would be informative if two phases were seen for dissociation of AAG from 
the labeled DNA. A faster phase would be due to the protein falling off from a 
nonspecifically bound complex and a slower phase would be due to the protein-DNA 
complex first unflipping then AAG dissociating from the DNA. Measuring two phases 
would allow for the determination of the unflipping rate constant. Taking this value along 
with the observed flipping rate constant obtained in the stopped-flow binding 
experiments described above, the flipping rate constant could be calculated. If both the 
forward and reverse rate constants for flipping were determined, the functional effects of 
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Chapter 5  
Preliminary NMR Studies to Characterize Changes in 




 The repair of single base damage is an important process within the cell because 
failure to repair it will lead to mutations that cause cancers and apoptosis. This type of 
repair is achieved through the base excision repair pathway (1-2). The first step of this 
pathway is for a DNA glycosylase to find the site of damage within the genome and 
excise the damaged base. One of these enzymes, alkyladenine DNA glycosylase (AAG) 
has been well studied. The crystal structure was determined (3-4), which is very 
informative but static and it doesn’t provide any information about the motions of the 
protein. The kinetics have also been studied (5-7) which provides a deeper understanding 
of the mechanism by which AAG excises damaged bases. This information is limited in 
its ability to describe the movements of the individual amino acids in the protein and the 
time scales during which they occur. In order to get this kind of information, studies of 
the dynamics of AAG must be performed.  
 Understanding the dynamics of AAG will help to build on the information that is 
already known about the enzyme. It will allow a deeper understanding of the molecular 
motions that occur as AAG binds to a DNA oligonucleotide. Specifically, it is possible to 
measure the motions of individual AAG residues and see what timescales these motions 
                                                 
4
 Special thanks to Evgenia Nikolova and Hashim Al-Hashimi, who we collaborated with on this project. 
Abigail Wolfe prepared the protein and DNA samples for the NMR experiments. Evgenia ran the NMR 
experiments and analyzed the data with some help from Abigail Wolfe. 
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occur on. The initial step of the base excision pathway is for AAG to recognize a 
damaged base. This is achieved by utilizing a base flipping mechanism. From the crystal 
structure, several key residues can be identified in the AAG active site that likely play a 
role in this base flipping mechanism. It would be very interesting to get dynamics 
information about these residues to see if and how the movements change when AAG 
goes from free in solution to bound to either undamaged or damaged DNA 
oligonucleotides.  
An excellent technique to address this question of dynamics is NMR. Many 
dynamics experiments have been done with NMR to address the molecular motions of 
proteins (8-9). A wide range of timescales (picoseconds to milliseconds) can be examined 
using different NMR experiments. We were interested specifically in doing residual 
dipolar coupling (RDC) experiments to probe the motions of AAG, focusing on the 
nanosecond to microsecond timescale (10-12). 
Since NMR experiments have not been performed for AAG before, a protocol for 
expression of AAG in minimal media was developed to allow for 
15
N labeling. A 
purification protocol had to be optimized as well to increase the yield of the protein. 
Preliminary HSQC NMR experiments were done to assess the spectrum of AAG in 




Materials and Methods 
Preparation of Uniformly 
15
N Labeled E12Q Δ80 AAG 
A plasmid containing the E125Q Δ80 AAG gene that can be induced by IPTG (5) 
was transformed into a BL21(DE3) strain of E. coli that also contained an expression 
plasmid for GroEL/GroES genes also inducible by IPTG (13). To uniformly 
15
N label the 
expressed protein, the cells were grown in M9 minimal media containing 
15
NH4Cl as the 
sole source of nitrogen (14). Once the OD600 reached 0.8, expression was induced with 
0.1 mM IPTG at 25 °C for ~36 hours. Cells were harvested, resuspended in lysis buffer 
(20 mM KPi, pH 7.4, 1 M NaCl, 10% glycerol, 0.1 % NP-40 and 5 mM BME) then 
frozen at -80 °C. 
 The protein was then purified according to the following protocol. All steps were 
performed at 4 °C unless otherwise indicated. The cells were thawed and protease 
inhibitors were added (1 mM PMSF and the recommended amount of a premade mixture 
of inhibitors from Sigma [containing AEBSF, E-64, bestatin, leupeptin, aprotinin, and 
sodium EDTA]) to prevent cleavage of AAG. Cells were lysed with 4 passes through a 
cell homogenizer. The lysate was cleared by centrifugation for 30 minutes at 38,000 x g. 
The DNA was removed from the supernatant by the addition of PEI, where 0.2% PEI was 
added then mixed for 30 minutes. The supernatant was cleared by centrifugation as above 
then loaded onto a 5 mL HisTrap Nickel column, which was run at 2 mL/minute. Once 
AAG was loaded, the column was washed with 10 column volumes of lysis buffer(see 
above) followed by 10 column volumes of Buffer A (20 mM KPi, pH 7.4, 150 mM NaCl, 
10% glycerol, 5 mM BME). Another wash of 6 column volumes of 3% Buffer B (20 mM 
KPi, pH 7.4, 150 mM NaCl, 10% glycerol, 500 mM imidizole, 5 mM BME) diluted with 
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Buffer A was done. AAG was eluted by running a linear gradient from 3-100% Buffer B 
(diluted with Buffer A) over 3 column volumes followed by washing with 8 column 
volumes of Buffer B. The fractions containing AAG (fractions 48-83; 1mL each) were 
pooled and 5 mM BME and 1 mM EDTA were added. 0.2 mg/mL of rhinovirus 3C 
protease was added and incubated at 16 °C overnight to cleave the His tag from the AAG 
protein. The solution containing AAG was diluted 4-fold with Buffer C (20 mM KPi, pH 
7.4, 100 mM NaCl, 10% glycerol, 5 mM BME, 1 mM EDTA) to decrease the ionic 
strength. Some protein precipitated during the dilution step, so the supernatant was 
cleared by centrifugation as above. In order to remove residual nucleic acids and AAG-
DNA complexes that were not precipitated in the PEI precipitation, AAG was passed 
through a 5 mL Q column. Some of the protein remained bound to the Q column, 
presumably through interactions with the DNA. From there, the protein solution was 
loaded onto a 5 mL S column. The column was run at 2 mL/minute and was washed with 
8 column volumes of Buffer C. AAG was eluted with a linear gradient of 0-50% Buffer 
D (20 mM KPi, pH 7.4, 2 M NaCl, 10% glycerol, 5 mM BME, 1 mM EDTA) diluted 
with Buffer C over 8 column volumes and a wash of 8 column volumes of Buffer D. The 
fractions containing AAG (fractions 17-22; 3mL each) were pooled and dialyzed into 
storage buffer (50 mM NaHEPES, pH 7.5, 100 mM NaCl, 10% glycerol, 1 mM EDTA, 1 
mM DTT). The concentration was determined by UV absorbance, using the calculated 






. AAG was then concentrated to 276 μM and 
stored at -80 °C. The yield from this preparation of 
15




Preparation of DNA Oligonucleotides 
5’phospho 2’deoxyethenoAMP (εAMP) was purchased from Sigma. The 13mer 
DNA oligonucleotides used in these experiments were obtained from commercial 
sources. The sequences are in Scheme 5.1. The A·T oligonucleotides, containing only 
normal deoxynucleotides, were synthesized and deprotected with standard 
phosphoramidite chemistry. These oligonucleotides were not purified prior to the 
annealing step. 
εA·T    5’- GACATGETTGCCT 
3’-ACTGTACTAACGG 
A·T   5’- GACATGATTGCCT 
3’-ACTGTACTAACGG 
Scheme 5.1 
Those oligonucleotides that contained a single εA lesion were synthesized and 
deprotected using Ultra-Mild chemistry according to the supplier’s recommendations. 
The εA-containing oligonucleotide was synthesized by the W. M. Keck Facility at Yale 
University (New Haven, CT). The oligonucleotides were desalted using SephadexG-25 
and purified using denaturing polyacrylamide gel electrophoresis, as previously described 
(15). The concentrations of the single-stranded oligonucleotides were determined from 
the absorbance at 260 nm, using the calculated extinction coefficients for all 
oligonucleotides except the one containing εA, where the extinction coefficient was 





 to account for the weaker absorbance of εA versus that of A 
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(16). The two oligonucleotide strands were annealed at a 1:1 ratio by being heated to 90 
°C and cooled slowly to 4 °C. 
Preparation of Samples for NMR Experiments 
 
15
N AAG was quickly thawed then dialyzed into NMR buffer (10 mM NaMES, 
pH 6.1, 100 mM NaCl, 1 mM DTT, 0.1 mM EDTA). 300 μL samples were made for 
each NMR experiment. The sample of AAG free in solution was prepared by mixing 270 
μL of 255 μM AAG with 30 μL D2O.  The sample of AAG bound to εA·T DNA was 
made by mixing 
15
N AAG and εA·T DNA at a 1:1 ratio to a final concentration of 250 
μM then D2O was added to 10%. Similarly, the sample of AAG bound to A·T DNA was 
made by mixing 
15
N AAG and A·T DNA at a 1:1.1 ratio to a final concentration of 196 
μM then D2O was added to 10%. The final sample of AAG bound to εAMP was prepared 
by mixing 196 μM AAG and 1M εAMP followed by the addition of D2O to 10%.  




N HSQC correlation maps of uniformly 
15
N labeled AAG in the free and 
bound form (see above for concentrations) were collected using a 30 ppm spectral width 
and 300 indirect points. Spectra were acquired with either 48 (free AAG, AAG bound to 
εA·T and AAG bound to εAMP) or 128 (AAG bound to A·T) scans for a total of ~ 1 day. 
All NMR experiments were performed at 25 °C using a Bruker Avance 600 MHz NMR 
spectrometer equipped with a 5 mm triple-resonance cryogenic probe. Data were 
processed and analyzed using nmrPipe (17).  
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Results and Discussion 
Preparation of NMR Samples 
For NMR, we need to use a catalytically inactive mutant, E125Q, and I found that 
this AAG mutant behaves very different from WT AAG during both expression and 
purification. Additionally, uniformly 
15
N labeled AAG was needed to perform the NMR 
experiments. In order to label the protein at each nitrogen, AAG was expressed in 
minimal media supplemented with 
15
NH4Cl. Optimal expression conditions were worked 
out by expressing AAG in minimal media without the label so that this valuable resource 
would not be wasted. The regular purification conditions for wildtype AAG was tried 
first and conditions were changed from there (5).  
There were several changes to the expression conditions to optimize them for 
expression of 
15
N-labeled E125Q AAG. The first was that the expression was done in M9 
minimal media to allow for incorporation of 
15
N into the protein, whereas typical 
expression of WT AAG is done in LB media. The expression of E125Q AAG was greatly 
enhanced by co-expressing the chaperone proteins, GroEL/GroES, but this co-expression 
is unnecessary for expressing WT AAG. While the best expression for both E125Q AAG 
and WT AAG is to induce at an OD of 0.8 and 25 °C, a much longer time after induction 
is needed for optimal expression of E125Q AAG (36 hours) as compared to WT AAG 
(~15 hours). 
 In addition to changing the conditions for expression, several changes in the 
purification protocol were necessary to optimize the yield of E125Q AAG during 
purification. E125Q AAG was more problematic during the purification because it binds 
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more tightly to genomic DNA than WT AAG does. One change to the purification 
protocol for E125Q AAG was to increase the NaCl concentration in the lysis buffer from 
0.5 to 1 M. During the PEI precipitation, it was necessary to increase the percent PEI to 
0.2% from 0.1% and increasing the mixing time from 10 to 30 minutes. These changes 
aid in removing more DNA that is bound to the protein. Finally, an additional step was 
added in order to remove any DNA that is still bound to E125Q AAG during the 
purification. Before loading onto the S column, the protein solution was passed through a 
Q column so that any DNA in the solution would bind to the Q column. However, free 
E125Q AAG would flow through the Q column and bind only to the S column. This step 
is unnecessary for WT AAG purification because DNA is no longer present in the 
solution after the PEI precipitation.  
While there are not many significant changes to the protocols, these changes do 
allow for much greater yield and purity of E125Q AAG, which is necessary when using 
expensive labeling reagents as in NMR experiments.  
Stability Problems with NMR Samples 
When running the NMR experiments on the free AAG sample, it was clear that 
AAG was not stable under the experimental conditions as it precipitated quickly. 
Although the HSQC spectrum was able to be measured, it would be desirable to find 
better conditions for future experiments so that AAG would remain stable throughout the 
experiment. Similar stability problems were seen with AAG in complex with the A·T 
DNA and the εAMP. Again, HSQC spectra were obtained with these samples, but better 
conditions (and more stable samples) would likely lead to better quality spectra in the 
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future. Stability problems were not seen with AAG in complex with εA·T DNA, 
presumably due to the fact that AAG binds strongly to the εA site. 
HSQC Spectra of AAG 
 From the HSQC NMR experiments, we see that the spectrum of AAG free in 
solution is well resolved with ~300 peaks (Figure 5.1). There are 210 amide nitrogens in 
the protein as well as some nitrogens in the side chains. This is a reasonable number of 
peaks to observe. The fact that the spectrum is well resolved indicates that this molecule 
is amenable to NMR techniques. 
 
Figure 5.1. HSQC Spectrum of Free AAG. The spectrum of free AAG gives many well resolved 
peaks. 
 When AAG is bound to εA·T DNA, there are changes to the chemical shifts for 
most of the peaks in the spectrum (Figure 5.2 and Figure 5.3). This indicates that there is a 




Figure 5.2.  HSQC Spectrum of AAG Bound to εA·T DNA. The spectrum of AAG bound to 
εA·T DNA gives many well resolved peaks, but they are broader than seen in the spectrum of 
free AAG (Figure 5.1). 
 
Figure 5.3. Comparison of the Spectra of Free AAG and AAG Bound to εA·T DNA. In black is 
the spectrum of free AAG (Figure 5.1) and in red is the spectrum of AAG bound to εA·T DNA 
(Figure 5.2) at a 1:1 ratio. Many of the AAG peaks are shifted between the free and bound states. 
Also, the peaks in the bound spectrum are visibly broader than those in the free AAG spectrum. 
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unbound states. This is consistent with the idea that a global shift in conformation is 
necessary for AAG to bind to DNA in the first place and many of the active site residues 
and other side chains that contact the DNA are anticipated to move in order to allow base 
flipping to occur. It is expected that at 1:1 ratio of AAG: εA·T DNA the protein will be 
specifically bound to the εA site, with the base fully flipped.  
In the spectrum of AAG bound to A-T DNA, the peaks are very broad (Figure 5.4 
and Figure 5.5). It is much harder to distinguish the individual peaks in this spectrum. 
Thus, it is difficult to correlate any peaks from this spectrum to that of free AAG. This 
likely indicates that there is not a single species as seen in the εA·T DNA spectrum. This 
would occur if AAG was bound at different sites all along the DNA strand, which is  
 
Figure 5.4.  HSQC Spectrum of AAG Bound to A·T DNA. In the spectrum of AAG bound to 
A·T DNA, the peaks are not very well resolved and they are much broader than seen in the 




expected when AAG is bound to undamaged DNA. It could also be due to heterogeneity 
in the unpurified DNA. 
 
Figure 5.5. Comparison of the Spectra of AAG bound to εA·T and A·T DNA oligonucleotides. In 
black is the spectrum of AAG bound to εA·T DNA (Figure 5.2) and in green is the spectrum of 
AAG bound to A·T DNA (Figure 5.4). The spectra are similar but there is much greater 
broadening of the peaks in the spectrum of AAG bound to A·T DNA. 
The spectrum for εAMP bound to AAG looks identical to that of AAG alone 
(Figure 5.6 and Figure 5.7). Not many peak shifts were expected for this complex in the 
first place since it is predicted to bind in the active site and only contact a few residues 
there but not cause a global shift in the protein as seen when DNA is bound. The lack of 
change in the spectrum could indicate that there is no change in the spectrum upon 
binding εAMP, a change does occur, but is not detected, or the nucleotide was not bound 




Figure 5.6.  HSQC Spectrum of AAG bound to εAMP. The spectrum of AAG bound to εAMP 
gives many well resolved peaks and is identical to the spectrum of free AAG (Figure 5.1). 
 
Figure 5.7. Comparison of the Spectra of Free AAG and AAG Bound to εAMP. The spectrum of 
free AAG (Figure 5.1) is in blue and the spectrum of AAG bound to εAMP (Figure 5.6) is in red. 
The plot is an overlay of the two spectra, which gives purple when the two spectra match exactly. 
The entire spectrum here is purple, showing that the two spectra are identical. 
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Since the peaks for the HSQC spectrum have not be previously assigned for 
AAG, it is impossible to know which peaks in the spectra correspond to which amino 
acids in AAG at this time. This information is imperative to determine which residues are 
moving when bound to different substrates. Nevertheless, the purification protocol 
described here and the HSQC spectra obtained will allow future NMR experiments to be 
done to determine the conformation of free AAG and additional DNA complexes and the 
timescales of motions of AAG. 
Future Directions 
 There are two possibilities for getting molecular information out of the NMR 
experiments. The first is to make differentially labeled AAG and assign the complete 
spectra for both the free enzyme and AAG bound to εA·T DNA. This option would 
require a more complicated labeling scheme and would take a relatively long time to 
complete the experiments and assign all of the residues. A second option would be to 
only label the tyrosines in AAG. This can be done by supplementing the minimal media 
with 
15
N-tyrosine and unlabeled NH4Cl, which would be a simple protein stock to make. 
AAG only has 6 tyrosine residues. Three of them are in the active site with two directly 
contacting the damaged base (as seen in the crystal structure). A fourth tyrosine, Y162, is 
intercalated into the DNA duplex, so it expected to move when AAG forms a flipped 
conformation with damaged DNA. A fifth tyrosine is also close to the DNA interface, 
while the final tyrosine is partially buried and not near the DNA or active site. Many of 
these tyrosine residues would be expected to be in a different environment when AAG 
binds to DNA and/or when the base is flipped. These would likely be the most interesting 
residues to look at even if the whole AAG spectrum was assigned. This, in addition to the 
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relative ease of making tyrosine labeled AAG, makes it an attractive avenue that could be 
pursued in the future. Once AAG was labeled at the tyrosines, it would be simple to run 
the dynamics experiments on the 6 peaks to see what types of motions are occurring for 
these residues as well as their time-scales in the presence and absence of damaged and 
undamaged DNA. To identify individual peaks in the spectra, single mutations could be 
made to change each tyrosine residue to some other amino acid, such as tryptophan (see 
Chapter 4 for data that these AAG mutants are active). By using single mutants, it would 
be possible to correlate the amino acid that was no longer tyrosine with the peak that 
disappeared from the spectra. This way, all six peaks in the spectra could be assigned to 
the tyrosines in AAG. It is possible that making the mutations could change the structure 
of AAG, which would shift the other 5 peaks that are seen in the spectra. This would 
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Description of Equations for Binding at Equimolar Concentrations of Enzyme and 
DNA.  
A general scheme for two-step, reversible binding is shown in Equation A.1. If 
the two steps can be directly distinguished, for example by different spectroscopic 
signals, then this can be simplified to Equation A.2, in which there is an observed rate 
constant for the first and second steps. The value of k1, obs is given by Equation A.3. 
However, at micromolar concentrations of AAG the rate of dissociation is significantly 
slower than the rate of association and therefore the observed rate constant is 
approximately equal to the rate constant for association (Equation A.4). Similarly, the 
observed rate constant for the second step is equal to the sum of the rate constants for the 
forward and reverse flipping steps (Equation A.5). As discussed in the text, the pulse-
chase experiment revealed that k2 is much greater than k-2, so that this simplifies to 
Equation A.6. 
 
      (A.1) 
     (A.2) 
k1, obs = k1 [E] + k-1      (A.3) 
k1, obs ~ k1 [E]       (A.4) 
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k2, obs = k2 + k-2       (A.5) 
k2, obs ~ k2        (A.6) 
 
For an irreversible binding step, the rate of formation of the complex is given by 
Equation A.7 (1). Under conditions in which both binding partners are present at the 
same concentration (i.e., [AAG] = [DNA]), then Equation A.8 is the appropriate 
expression. As described by Fersht, integration gives a relatively simple expression 
(Equation A.9). This can be rearranged to solve for the concentration of the bound 
species as a function of time (Equation A.10). The second step of the binding reaction is a 
first order reaction that is described by a single exponential (Equation A.11).  
 
d[E•S]/dt = k1 [E][S]       (A.7) 
d[E•S]/dt = k1[E]0
2
       (A.8) 









       (A.10) 




The fluorescence of the sample (F) can be considered to be a linear combination 
of the fluorescence of each of the species present in solution at a given time after mixing 
(Equation A.12). In this expression Ffree is the fluorescence of the unbound A-DNA, 
∆FE•S is the change in fluorescence between free DNA and the E•S complex, and ∆FE•S’ is 
the change in fluorescence between the E•S and the E•S’ complexes. Substitution of 
Equation A.12 with the time dependence for the formation of the initial E•S complex 
(Equation A.10) and the time dependence of the formation of E•S’ (Equation A.11) gives 
Equation A.13 that was used in the text, in which Ffree = C, ∆FE•S = Y, and ∆FE•S’ = Z. 
 
F = Ffree + ∆FE•S[E•S] + ∆FE•S’ [E•S’]    (A.12) 
  











k 2,obst )    (A.13) 
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